FORM | ||
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | |
Commission File Number: | ||
(State of incorporation) | (I.R.S. employer identification no.) | |||
(Address of principal executive offices) | (Zip code) | |||
(Registrant's telephone number, including area code) | |||
Securities registered pursuant to Section 12(b) of the Act: | ||||
Title of each class | Trading Symbol | Name of each exchange on which registered | ||
☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company | |||
Item Number | Page | Item Number | Page | |||
PART I. FINANCIAL INFORMATION | PART I (CONTINUED) | |||||
1 | Unaudited Consolidated Financial Statements of Ambac Financial Group, Inc. and Subsidiaries | 3 | ||||
4 | ||||||
PART II. OTHER INFORMATION | ||||||
1 | ||||||
1A | ||||||
2 | 2 | |||||
3 | ||||||
5 | Other Information | |||||
6 | Exhibits | |||||
June 30, | December 31, | ||||||
(Dollars in millions, except share data) (June 30, 2020 (Unaudited)) | 2020 | 2019 | |||||
Assets: | |||||||
Investments: | |||||||
Fixed income securities, at fair value (amortized cost of $2,126 and $2,450) | $ | $ | |||||
Short-term investments pledged as collateral, at fair value (amortized cost of $155 and $85) | |||||||
Short-term investments, at fair value (amortized cost of $691 and $653) | |||||||
Other investments (includes $352 and $432 at fair value) | |||||||
Total investments (net of allowance for credit losses of $0 at June 30, 2020) | |||||||
Cash and cash equivalents | |||||||
Restricted cash | |||||||
Premium receivables (net of allowance for credit losses of $16 at June 30, 2020) | |||||||
Reinsurance recoverable on paid and unpaid losses (net of allowance for credit losses of $0 at June 30, 2020) | |||||||
Deferred ceded premium | |||||||
Subrogation recoverable | |||||||
Derivative assets | |||||||
Current taxes | |||||||
Insurance intangible asset | |||||||
Other assets | |||||||
Variable interest entity assets: | |||||||
Fixed income securities, at fair value | |||||||
Restricted cash | |||||||
Loans, at fair value | |||||||
Derivative assets | |||||||
Other assets | |||||||
Total assets | $ | $ | |||||
Liabilities and Stockholders’ Equity: | |||||||
Liabilities: | |||||||
Unearned premiums | $ | $ | |||||
Loss and loss expense reserves | |||||||
Ceded premiums payable | |||||||
Deferred taxes | |||||||
Long-term debt | |||||||
Accrued interest payable | |||||||
Derivative liabilities | |||||||
Other liabilities | |||||||
Variable interest entity liabilities: | |||||||
Accrued interest payable | |||||||
Long-term debt (includes $3,953 and $4,351 at fair value) | |||||||
Derivative liabilities | |||||||
Total liabilities | |||||||
Commitments and contingencies (See Note 11) | |||||||
Stockholders’ equity: | |||||||
Preferred stock, par value $0.01 per share; 20,000,000 shares authorized shares; issued and outstanding shares—none | |||||||
Common stock, par value $0.01 per share; 130,000,000 shares authorized; issued shares: 45,865,081 and 45,571,743 | |||||||
Additional paid-in capital | |||||||
Accumulated other comprehensive income (loss) | ( | ) | |||||
Retained earnings | |||||||
Treasury stock, shares at cost: 56,825 and 16,343 | ( | ) | |||||
Total Ambac Financial Group, Inc. stockholders’ equity | |||||||
Noncontrolling interest | |||||||
Total stockholders’ equity | |||||||
Total liabilities and stockholders’ equity | $ | $ | |||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
(Dollars in millions, except share data) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Revenues: | ||||||||||||||||
Net premiums earned | $ | $ | $ | |||||||||||||
Net investment income | ||||||||||||||||
Net realized investment gains (losses) | ||||||||||||||||
Net gains (losses) on derivative contracts | ( | ) | ( | ) | ( | ) | ||||||||||
Other income (expense) | ( | ) | ( | ) | ||||||||||||
Income (loss) on variable interest entities | ||||||||||||||||
Total revenues | ||||||||||||||||
Expenses: | ||||||||||||||||
Losses and loss expenses (benefit) | ( | ) | ( | ) | ||||||||||||
Insurance intangible amortization | ||||||||||||||||
Operating expenses | ||||||||||||||||
Interest expense | ||||||||||||||||
Total expenses | ||||||||||||||||
Pre-tax income (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Provision (benefit) for income taxes | ( | ) | ||||||||||||||
Net income (loss) attributable to common stockholders | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Other comprehensive income (loss), after tax: | ||||||||||||||||
Net income (loss) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Unrealized gains (losses) on securities, net of income tax provision (benefit) of $1, $(7), $1 and $(8) | ( | ) | ||||||||||||||
Gains (losses) on foreign currency translation, net of income tax provision (benefit) of $0, $0, $0 and $0 | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Credit risk changes of fair value option liabilities, net of income tax provision (benefit) of $(0), $0, $0 and $0 | ( | ) | ||||||||||||||
Changes to postretirement benefit, net of income tax provision (benefit) of $0, $0, $0 and $0 | ( | ) | ||||||||||||||
Total other comprehensive income (loss), net of income tax | ( | ) | ( | ) | ||||||||||||
Total comprehensive income (loss) attributable to common stockholders | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||
Net income (loss) per share attributable to common stockholders: | ||||||||||||||||
Basic | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Diluted | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||
Weighted average number of common shares outstanding: | ||||||||||||||||
Basic | ||||||||||||||||
Diluted | ||||||||||||||||
Ambac Financial Group, Inc. | |||||||||||||||||||||||||||||||
(Dollars in millions) | Total | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Preferred Stock | Common Stock | Additional Paid-in Capital | Common Stock Held in Treasury, at Cost | Noncontrolling Interest | |||||||||||||||||||||||
Balance at March 31, 2020 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
Total comprehensive income (loss) | ( | ) | |||||||||||||||||||||||||||||
Stock-based compensation | |||||||||||||||||||||||||||||||
Cost of shares (acquired) issued under equity plan | ( | ) | |||||||||||||||||||||||||||||
Balance at June 30, 2020 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
Balance at March 31, 2019 | $ | $ | $ | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||||
Total comprehensive income (loss) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
Stock-based compensation | |||||||||||||||||||||||||||||||
Cost of shares (acquired) issued under equity plan | ( | ) | |||||||||||||||||||||||||||||
Re-issuance of Ambac Assurance auction market preferred shares | |||||||||||||||||||||||||||||||
Balance at June 30, 2019 | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
Ambac Financial Group, Inc. | |||||||||||||||||||||||||||||||
(Dollars in millions) | Total | Retained Earnings | Accumulated Other Comprehensive Income (Loss) | Preferred Stock | Common Stock | Additional Paid-in Capital | Common Stock Held in Treasury, at Cost | Noncontrolling Interest | |||||||||||||||||||||||
Balance at January 1, 2020 | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
Total comprehensive income (loss) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
Adjustment to initially apply ASU 2016-13 | ( | ) | ( | ) | — | — | — | — | — | ||||||||||||||||||||||
Stock-based compensation | |||||||||||||||||||||||||||||||
Cost of shares (acquired) issued under equity plan | ( | ) | ( | ) | ( | ) | |||||||||||||||||||||||||
Balance at June 30, 2020 | $ | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
Balance at January 1, 2019 | $ | $ | $ | ( | ) | $ | $ | $ | $ | $ | |||||||||||||||||||||
Total comprehensive income (loss) | ( | ) | ( | ) | |||||||||||||||||||||||||||
Stock-based compensation | |||||||||||||||||||||||||||||||
Cost of shares (acquired) issued under equity plan | ( | ) | ( | ) | |||||||||||||||||||||||||||
Issuance of common stock | |||||||||||||||||||||||||||||||
Exchange of auction market preferred shares | |||||||||||||||||||||||||||||||
Balance at June 30, 2019 | $ | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||||
Six Months Ended June 30, | ||||||||
(Dollars in millions) | 2020 | 2019 | ||||||
Cash flows from operating activities: | ||||||||
Net income (loss) | $ | ( | ) | $ | ( | ) | ||
Adjustments to reconcile net income to net cash used in operating activities: | ||||||||
Amortization of bond premium and discount | ( | ) | ( | ) | ||||
Share-based compensation | ||||||||
Deferred income taxes | ( | ) | ( | ) | ||||
Current income taxes | ( | ) | ||||||
Unearned premiums, net | ( | ) | ( | ) | ||||
Losses and loss expenses, net | ( | ) | ||||||
Ceded premiums payable | ( | ) | ( | ) | ||||
Premium receivables | ||||||||
Accrued interest payable | ||||||||
Amortization of insurance intangible assets | ||||||||
Net mark-to-market (gains) losses | ( | ) | ||||||
Net realized investment gains | ( | ) | ( | ) | ||||
Variable interest entity activities | ( | ) | ( | ) | ||||
Derivative assets and liabilities | ( | ) | ||||||
Other, net | ||||||||
Net cash used in operating activities | ( | ) | ( | ) | ||||
Cash flows from investing activities: | ||||||||
Proceeds from sales of bonds | ||||||||
Proceeds from matured bonds | ||||||||
Purchases of bonds | ( | ) | ( | ) | ||||
Proceeds from sales of other invested assets | ||||||||
Purchases of other invested assets | ( | ) | ( | ) | ||||
Change in short-term investments | ( | ) | ( | ) | ||||
Change in cash collateral receivable | ( | ) | ||||||
Proceeds from paydowns of consolidated VIE assets | ||||||||
Other, net | ( | ) | ||||||
Net cash provided by (used in) investing activities | ||||||||
Cash flows from financing activities: | ||||||||
Proceeds from issuance of Ambac UK debt | ||||||||
Paydowns of Ambac note | ( | ) | ( | ) | ||||
Issuance of auction market preferred shares of Ambac Assurance | ||||||||
Tax payments related to shares withheld for share-based compensation plans | ( | ) | ( | ) | ||||
Payments of consolidated VIE liabilities | ( | ) | ( | ) | ||||
Net cash used in financing activities | ( | ) | ( | ) | ||||
Effect of foreign exchange on cash, cash equivalents and restricted cash | ||||||||
Net cash flow | ( | ) | ( | ) | ||||
Cash, cash equivalents, and restricted cash at beginning of period | ||||||||
Cash, cash equivalents, and restricted cash at end of period | $ | $ | ||||||
• | Active runoff of Ambac Assurance and its subsidiaries through transaction terminations, policy commutations, reinsurance, settlements and restructurings, with a focus on our watch list credits and known and potential future adversely classified credits, that we believe will improve our risk profile, and maximizing the risk-adjusted return on invested assets; |
• | Ongoing rationalization of Ambac's capital and liability structures; |
• | Loss recovery through active litigation management and exercise of contractual and legal rights; |
• | Ongoing review of the effectiveness and efficiency of Ambac's operating platform; and |
• | Evaluation of opportunities in certain business sectors that meet acceptable criteria that will generate long-term stockholder value with attractive risk-adjusted returns. |
Supplemental Disclosure of Cash Flow Information | Six Months Ended June 30, | |||||||
2020 | 2019 | |||||||
Cash paid during the period for: | ||||||||
Income taxes | $ | $ | ||||||
Interest on long-term debt | ||||||||
Non-cash financing activities: | ||||||||
Exchange of investments in Puerto Rico COFINA bonds for new bonds issued in the Plan of Adjustment | $ | — | $ | |||||
June 30, | ||||||||
2020 | 2019 | |||||||
Reconciliation of cash, cash equivalents, and restricted cash reported within the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows: | ||||||||
Cash and cash equivalents | $ | $ | ||||||
Restricted cash | ||||||||
Variable Interest Entity Restricted cash | ||||||||
Total cash, cash equivalents, and restricted cash shown on the Consolidated Statements of Cash Flows | $ | $ | ||||||
• | Removals: 1) Amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, 2) Policy for timing of transfers between levels, and 3) Valuation processes for Level 3 fair value measurements. |
• | Modifications: 1) For investments in certain entities that calculate net asset value, disclosures are required for the timing of liquidation of an investee's assets and the date when restrictions from redemption might lapse, only if the investee has communicated the timing to the reporting entity or publicly announced it and 2) Clarification that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date and not possible future changes. |
• | Additions: 1) Changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and 2) Range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. Alternatively, an entity may disclose other quantitative information (such as the median or arithmetic average) if it determines that it is a more reasonable and rational method to reflect the distribution of unobservable inputs used. |
• | Ambac provides financial guarantees, including credit derivative contracts, for various debt obligations issued by special purpose entities, including VIEs ("FG VIEs"); |
• | Ambac sponsors special purpose entities that issued notes to investors for various purposes; and |
• | Ambac is an investor in collateralized debt obligations, mortgage-backed and other asset-backed securities issued by VIEs and its ownership interest is generally insignificant to the VIE and/or Ambac does not have rights that direct the activities that are most significant to such VIE. |
• | We determined that Ambac’s subsidiaries generally have the obligation to absorb a FG VIE's expected losses given that they have issued financial guarantees supporting certain liabilities (and in some cases certain assets). As further described below, Ambac consolidates certain FG VIEs in cases where we also have the power to direct the activities that most significantly impact the VIE’s economic performance due to one or more of the following: (i) the transaction experiencing deterioration and breaching performance triggers, giving Ambac the ability to exercise certain control rights, (ii) Ambac being involved in the design of the VIE and receiving control rights from its inception, such as may occur from loss remediation activities, or (iii) the transaction not experiencing deterioration, however due to the passive nature of the VIE, Ambac's contingent control rights upon a future breach of performance triggers is considered to be the power over the most significant activity. |
• | A VIE is deconsolidated in the period that Ambac no longer has such control rights, which could occur in connection with the execution of remediation activities on the transaction or amortization of insured exposure, either of which may reduce the degree of Ambac’s control over a VIE. |
• | Assets and liabilities of FG VIEs that are consolidated are reported within Variable interest entity assets or Variable interest entity liabilities on the Consolidated Balance Sheets. |
• | The election to use the fair value option is made on an instrument by instrument basis. Ambac has elected the fair value option for consolidated FG VIE financial assets and financial liabilities, except in cases where Ambac was involved in the design of the VIE and was granted control rights at its inception. |
◦ | When the fair value option is elected, changes in the fair value of the FG VIE's financial assets and liabilities are reported within Income (loss) on variable interest entities in the Consolidated Statements of Total Comprehensive Income (Loss), except for the portion of the total change in fair value of financial liabilities caused by changes in the instrument-specific credit risk which is presented separately in Other comprehensive income (loss). |
◦ | In cases where the fair value option has not been elected, the FG VIE's invested assets are fixed income securities and are considered available-for-sale as defined by the Investments - Debt Securities Topic of the ASC. These assets are reported in the financial statements at fair value with unrealized gains and losses reflected in Accumulated Other Comprehensive Income in Stockholders' Equity. |
• | Upon initial consolidation of a FG VIE, Ambac recognizes a gain or loss in earnings for the difference between: (i) the fair value of the consideration paid, the fair value of any non-controlling interests and the reported amount of any previously held interests and (ii) the net amount, as measured on a fair value basis, of the assets and liabilities consolidated. Upon deconsolidation of a FG VIE, we recognize a gain or loss for the difference between: (i) the fair value of any consideration received, the fair value of any retained non-controlling investment in the VIE and the carrying amount of any non-controlling interest in the VIE and (ii) the carrying amount of the VIE’s assets and liabilities. Gains or losses from consolidation and deconsolidation that are reported in earnings are reported within Income (loss) on variable interest entities on the Consolidated Statements of Total Comprehensive Income (Loss). |
• | The impact of consolidating such FG VIEs on Ambac’s balance sheet is the elimination of transactions between the consolidated FG VIEs and Ambac’s operating subsidiaries and the inclusion of the FG VIE’s third party assets and liabilities. For a financial guarantee insurance policy issued to a consolidated VIE, Ambac does not reflect the financial guarantee insurance policy in accordance with the related insurance accounting rules under the Financial Services – |
June 30, 2020 | December 31, 2019 | ||||||||||||||||||||||
Ambac UK | Ambac Assurance | Total VIEs | Ambac UK | Ambac Assurance | Total VIEs | ||||||||||||||||||
Fixed income securities, at fair value: | |||||||||||||||||||||||
Corporate obligations, fair value option | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Municipal obligations, available-for-sale (1) | |||||||||||||||||||||||
Total FG VIE fixed income securities, at fair value | |||||||||||||||||||||||
Restricted cash | |||||||||||||||||||||||
Loans, at fair value (2) | |||||||||||||||||||||||
Derivative assets | |||||||||||||||||||||||
Other assets | |||||||||||||||||||||||
Total FG VIE assets | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Accrued interest payable | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Long-term debt: | |||||||||||||||||||||||
Long-term debt, at fair value (3) | |||||||||||||||||||||||
Long-term debt, at par less unamortized discount | |||||||||||||||||||||||
Total long-term debt | |||||||||||||||||||||||
Derivative liabilities | |||||||||||||||||||||||
Total FG VIE liabilities | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Number of FG VIEs consolidated | |||||||||||||||||||||||
(1) | Available-for-sale FG VIE fixed income securities consist of municipal obligations with an amortized cost basis of $ |
(2) | The unpaid principal balances of loan assets carried at fair value were $ |
(3) | The unpaid principal balances of long-term debt carried at fair value were $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Net change in fair value of VIE assets and liabilities reported under the fair value option | $ | ( | ) | $ | $ | ( | ) | $ | ||||||||
Less: Credit risk changes of fair value option long-term debt reported through other comprehensive income (loss) | ( | ) | ||||||||||||||
Net change in fair value of VIE assets and liabilities reported in earnings | ( | ) | ( | ) | ||||||||||||
Investment income on available-for-sale securities | ||||||||||||||||
Net realized investment gains (losses) on available-for-sale securities | ||||||||||||||||
Interest expense on long-term debt carried at par less unamortized cost | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Other expenses | ( | ) | ( | ) | ||||||||||||
Gain (loss) from consolidating FG VIEs | ||||||||||||||||
Gain (loss) from de-consolidating FG VIEs | — | — | — | — | ||||||||||||
Income (loss) on variable interest entities | $ | $ | $ | $ | ||||||||||||
Carrying Value of Assets and Liabilities | |||||||||||||||
Maximum Exposure To Loss (1) | Insurance Assets (2) | Insurance Liabilities (3) | Net Derivative Assets (Liabilities) (4) | ||||||||||||
June 30, 2020: | |||||||||||||||
Global structured finance: | |||||||||||||||
Mortgage-backed—residential | $ | $ | $ | $ | |||||||||||
Other consumer asset-backed | |||||||||||||||
Other commercial asset-backed | |||||||||||||||
Other | |||||||||||||||
Total global structured finance | |||||||||||||||
Global public finance | ( | ) | |||||||||||||
Total | $ | $ | $ | $ | |||||||||||
December 31, 2019: | |||||||||||||||
Global structured finance: | |||||||||||||||
Mortgage-backed—residential | $ | $ | $ | $ | |||||||||||
Other consumer asset-backed | |||||||||||||||
Other commercial asset-backed | |||||||||||||||
Other | |||||||||||||||
Total global structured finance | |||||||||||||||
Global public finance | |||||||||||||||
Total | $ | $ | $ | $ | |||||||||||
(1) | Maximum exposure to loss represents the maximum future payments of principal and interest on insured obligations and derivative contracts. Ambac’s maximum exposure to loss does not include the benefit of any financial instruments (such as reinsurance or hedge contracts) that Ambac may utilize to mitigate the risks associated with these variable interests. |
(2) | Insurance assets represent the amount included in “Premium receivables” and “Subrogation recoverable” for financial guarantee insurance contracts on Ambac’s Consolidated Balance Sheets. |
(3) | Insurance liabilities represent the amount included in “Loss and loss expense reserves” and “Unearned premiums” for financial guarantee insurance contracts on Ambac’s Consolidated Balance Sheets. |
(4) | Net derivative assets (liabilities) represent the fair value recognized on credit derivative contracts and interest rate swaps on Ambac’s Consolidated Balance Sheets. |
• | Total principal amount of debt outstanding was $ |
• | Insurance premiums paid to Ambac Assurance by this entity are earned in a manner consistent with other insurance policies, over the risk period. Additionally, any losses incurred on such insurance policies are included in Ambac’s Consolidated Statements of Total Comprehensive Income (Loss). Under the terms of an Administrative Agency Agreement, Ambac provides certain administrative duties, primarily collecting amounts due on the obligations and making interest payments on the MTNs. |
Unrealized Gains (Losses) on Available for Sale Securities (1) | Amortization of Postretirement Benefit (1) | Gain (Loss) on Foreign Currency Translation (1) | Credit Risk Changes of Fair Value Option Liabilities (1) (2) | Total | ||||||||||||||||
Three Months Ended June 30, 2020: | ||||||||||||||||||||
Beginning Balance | $ | $ | $ | ( | ) | $ | $ | ( | ) | |||||||||||
Other comprehensive income (loss) before reclassifications | ( | ) | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | ( | ) | ( | ) | ( | ) | ||||||||||||||
Net current period other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||||||
Balance at June 30, 2020 | $ | $ | $ | ( | ) | $ | $ | ( | ) | |||||||||||
Three Months Ended June 30, 2019: | ||||||||||||||||||||
Beginning Balance | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||
Other comprehensive income (loss) before reclassifications | ( | ) | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||||||
Net current period other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||||||
Balance at June 30, 2019 | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||
Unrealized Gains (Losses) on Available for Sale Securities (1) | Amortization of Postretirement Benefit (1) | Gain (Loss) on Foreign Currency Translation (1) | Credit Risk Changes of Fair Value Option Liabilities (1) (2) | Total | ||||||||||||||||
Six Months Ended June 30, 2020: | ||||||||||||||||||||
Beginning Balance | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||
Adjustment to opening balance, net of taxes (3) | — | — | — | |||||||||||||||||
Adjusted balance, beginning of period | ( | ) | ( | ) | ||||||||||||||||
Other comprehensive income (loss) before reclassifications | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss) | ( | ) | ( | ) | ||||||||||||||||
Net current period other comprehensive income (loss) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||
Balance at June 30, 2020 | $ | $ | $ | ( | ) | $ | $ | ( | ) | |||||||||||
Six Months Ended June 30, 2019: | ||||||||||||||||||||
Beginning Balance | $ | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||||||
Adjustments to opening balance, net of taxes (3) | — | — | — | |||||||||||||||||
Adjusted balance, beginning of period | ( | ) | ( | ) | ( | ) | ||||||||||||||
Other comprehensive income before reclassifications | ( | ) | ||||||||||||||||||
Amounts reclassified from accumulated other comprehensive income | ( | ) | ( | ) | ( | ) | ||||||||||||||
Net current period other comprehensive income | $ | $ | $ | ( | ) | $ | $ | |||||||||||||
Balance at June 30, 2019 | $ | $ | $ | ( | ) | $ | ( | ) | $ | |||||||||||
(1) | All amounts are net of tax and noncontrolling interest. Amounts in parentheses indicate reductions to Accumulated Other Comprehensive Income. |
(2) | Represents the changes in fair value attributable to instrument-specific credit risk of liabilities for which the fair value option is elected. |
Details about Accumulated Other Comprehensive Income Components | Amount Reclassified from Accumulated Other Comprehensive Income | Affected Line Item in the Consolidated Statement of Total Comprehensive Income (Loss) | ||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||||
Unrealized Gains (Losses) on Available-for-Sale Securities | ||||||||||||||||||
$ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | Net realized investment gains (losses) and other-than-temporary impairment losses | ||||||
Provision for income taxes | ||||||||||||||||||
$ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | Net of tax and noncontrolling interest | ||||||
Amortization of Postretirement Benefit | ||||||||||||||||||
Prior service cost | $ | $ | $ | $ | Other income | |||||||||||||
Actuarial (losses) | Other income | |||||||||||||||||
( | ) | Total before tax | ||||||||||||||||
Provision for income taxes | ||||||||||||||||||
$ | $ | $ | $ | ( | ) | Net of tax and noncontrolling interest | ||||||||||||
Credit risk changes of fair value option liabilities | ||||||||||||||||||
$ | ( | ) | $ | $ | $ | Credit Risk Changes of Fair Value Option Liabilities | ||||||||||||
Provision for income taxes | ||||||||||||||||||
$ | ( | ) | $ | $ | $ | Net of tax and noncontrolling interest | ||||||||||||
Total reclassifications for the period | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | Net of tax and noncontrolling interest | |||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||
Basic weighted average shares outstanding | ||||||||||||
Effect of potential dilutive shares (1): | ||||||||||||
Stock options | ||||||||||||
Warrants | ||||||||||||
Restricted stock units | ||||||||||||
Performance stock units (2) | ||||||||||||
Diluted weighted average shares outstanding | ||||||||||||
Anti-dilutive shares excluded from the above reconciliation: | ||||||||||||
Stock options | ||||||||||||
Warrants | ||||||||||||
Restricted stock units | ||||||||||||
Performance stock units (2) | ||||||||||||
(1) | For the three and six months ended June 30, 2020, and the three and six months ended June 30, 2019, Ambac had a net loss and accordingly excluded all potentially dilutive securities from the determination of diluted loss per share as their impact was anti-dilutive. |
(2) | Performance stock units are reflected based on the performance metrics through the balance sheet date. Vesting of these units is contingent upon meeting certain performance metrics. Although a portion of these performance metrics have been achieved as of the respective period end, it is possible that awards may no longer meet the metric at the end of the performance period. |
Six Months Ended June 30, | ||||||||
2020 | 2019 | |||||||
Beginning premium receivable | $ | $ | ||||||
Adjustment to initially apply ASU 2016-13 | ( | ) | — | |||||
Premium receipts | ( | ) | ( | ) | ||||
Adjustments for changes in expected and contractual cash flows (1) | ( | ) | ||||||
Accretion of premium receivable discount | ||||||||
Changes to allowance for credit losses | ( | ) | ( | ) | ||||
Other adjustments (including foreign exchange) | ( | ) | ( | ) | ||||
Ending premium receivable (2) | $ | $ | ||||||
(1) | Adjustments for changes in expected and contractual cash flows primarily due to changes in indexation rates on certain UK transactions partially offset by reductions in insured exposure as a result of early policy terminations and unscheduled principal paydowns. |
(2) | Premium receivable includes premiums to be received in foreign denominated currencies most notably in British Pounds and Euros. At June 30, 2020 and 2019, premium receivables include British Pounds of $ |
Three Months Ended June 30, | |||||||||||||||
2020 | 2019 | ||||||||||||||
Written | Earned | Written | Earned | ||||||||||||
Direct | $ | ( | ) | $ | $ | ( | ) | $ | |||||||
Assumed | |||||||||||||||
Ceded | |||||||||||||||
Net premiums | $ | $ | $ | ( | ) | $ | |||||||||
Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | ||||||||||||||
Written | Earned | Written | Earned | ||||||||||||
Direct | $ | $ | $ | ( | ) | $ | |||||||||
Assumed | |||||||||||||||
Ceded | ( | ) | ( | ) | |||||||||||
Net premiums | $ | $ | $ | ( | ) | $ | |||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
United States | $ | $ | $ | $ | |||||||||||
United Kingdom | |||||||||||||||
Other international | ( | ) | ( | ) | ( | ) | ( | ) | |||||||
Total | $ | $ | $ | $ | |||||||||||
Future Premiums to be Collected (1) | Future Premiums to be Earned Net of Reinsurance (2) | ||||||
Three months ended: | |||||||
September 30, 2020 | $ | $ | |||||
December 31, 2020 | |||||||
Twelve months ended: | |||||||
December 31, 2021 | |||||||
December 31, 2022 | |||||||
December 31, 2023 | |||||||
December 31, 2024 | |||||||
Five years ended: | |||||||
December 31, 2029 | |||||||
December 31, 2034 | |||||||
December 31, 2039 | |||||||
December 31, 2044 | |||||||
December 31, 2049 | |||||||
December 31, 2054 | |||||||
Total | $ | $ | |||||
(1) | Future premiums to be collected are undiscounted, gross of allowance for credit losses, and are used to derive the discounted premium receivable asset recorded on Ambac's balance sheet. |
(2) |
Surveillance Categories as of June 30, 2020 | |||||||||||||||||||||||
Type of Guaranteed Bond | I | IA | II | III | IV | Total | |||||||||||||||||
Public Finance: | |||||||||||||||||||||||
Housing revenue | $ | $ | $ | $ | $ | $ | |||||||||||||||||
Other | |||||||||||||||||||||||
Total Public Finance | |||||||||||||||||||||||
Structured Finance: | |||||||||||||||||||||||
Mortgage-backed and home equity | |||||||||||||||||||||||
Structured insurance | |||||||||||||||||||||||
Student loan | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
Total Structured Finance | |||||||||||||||||||||||
International: | |||||||||||||||||||||||
Sovereign/sub-sovereign | |||||||||||||||||||||||
Investor-owned and public utilities | |||||||||||||||||||||||
Other | |||||||||||||||||||||||
Total International | |||||||||||||||||||||||
Total (1) | $ | $ | $ | $ | $ | $ | |||||||||||||||||
(1) | The underwriting origination dates for all policies included are greater than five years prior to the current reporting date. |
Three Months Ended June 30, 2020 | Six Months Ended June 30, 2020 | |||||||
Beginning balance (1) | $ | $ | ||||||
Current period provision (2) | ||||||||
Write-offs of the allowance | ||||||||
Recoveries of previously written-off amounts | ||||||||
Ending balance | $ | 16 | $ | |||||
(1) | At December 31, 2019, $ |
(2) | The six months ended June 30, 2020, includes $ |
June 30, 2020: | December 31, 2019: | |||||||||||||||||||||||||||||||
Present Value of Expected Net Cash Flows | Unearned Premium Revenue | Gross Loss and Loss Expense Reserves | Present Value of Expected Net Cash Flows | Unearned Premium Revenue | Gross Loss and Loss Expense Reserves | |||||||||||||||||||||||||||
Balance Sheet Line Item | Claims and Loss Expenses | Recoveries | Claims and Loss Expenses | Recoveries | ||||||||||||||||||||||||||||
Loss and loss expense reserves | $ | $ | ( | ) | $ | ( | ) | $ | $ | $ | ( | ) | $ | ( | ) | $ | ||||||||||||||||
Subrogation recoverable | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||||
Totals | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | $ | ( | ) | $ | ( | ) | ||||||||||||
Six Months Ended June 30, | |||||||
2020 | 2019 | ||||||
Beginning gross loss and loss expense reserves | $ | ( | ) | $ | ( | ) | |
Reinsurance recoverable | |||||||
Beginning balance of net loss and loss expense reserves | ( | ) | ( | ) | |||
Losses and loss expenses (benefit): | |||||||
Current year | |||||||
Prior years | ( | ) | |||||
Total (1) (2) | ( | ) | |||||
Loss and loss expenses paid (recovered): | |||||||
Current year | |||||||
Prior years | |||||||
Total | |||||||
Foreign exchange effect | ( | ) | |||||
Ending net loss and loss expense reserves | ( | ) | ( | ) | |||
Impact of VIE consolidation | ( | ) | |||||
Reinsurance recoverable (3) | |||||||
Ending gross loss and loss expense reserves | $ | ( | ) | $ | ( | ) | |
(1) | Total losses and loss expenses (benefit) includes $( |
(2) | Ambac records the impact of estimated recoveries related to securitized loans in RMBS transactions that breached certain representations and warranties ("R&W"s) by transaction sponsors within losses and loss expenses (benefit). The losses and loss expense (benefit) incurred associated with changes in estimated R&Ws for the six months ended June 30, 2020 and 2019, was $( |
(3) | Represents reinsurance recoverable on future loss and loss expenses. Additionally, the Balance Sheet line "Reinsurance recoverable on paid and unpaid losses" includes reinsurance recoverables (payables) of $ |
Surveillance Categories as of June 30, 2020 | |||||||||||||||||||||||||||
I | IA | II | III | IV | V | Total | |||||||||||||||||||||
Number of policies | |||||||||||||||||||||||||||
Remaining weighted-average contract period (in years) (1) | |||||||||||||||||||||||||||
Gross insured contractual payments outstanding: | |||||||||||||||||||||||||||
Principal | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Interest | |||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Gross undiscounted claim liability | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Discount, gross claim liability | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||
Gross claim liability before all subrogation and before reinsurance | |||||||||||||||||||||||||||
Less: | |||||||||||||||||||||||||||
Gross RMBS subrogation (2) | ( | ) | ( | ) | |||||||||||||||||||||||
Discount, RMBS subrogation | |||||||||||||||||||||||||||
Discounted RMBS subrogation, before reinsurance | ( | ) | ( | ) | |||||||||||||||||||||||
Less: | |||||||||||||||||||||||||||
Gross other subrogation (3) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||
Discount, other subrogation | |||||||||||||||||||||||||||
Discounted other subrogation, before reinsurance | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||
Gross claim liability, net of all subrogation and discounts, before reinsurance | ( | ) | ( | ) | |||||||||||||||||||||||
Less: Unearned premium revenue | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||
Plus: Loss expense reserves | |||||||||||||||||||||||||||
Gross loss and loss expense reserves | $ | $ | $ | $ | $ | ( | ) | $ | $ | ( | ) | ||||||||||||||||
Reinsurance recoverable reported on Balance Sheet (4) | $ | $ | $ | $ | $ | ( | ) | $ | $ | ||||||||||||||||||
(1) | Remaining weighted-average contract period is weighted based on projected gross claims over the lives of the respective policies. |
(2) | RMBS subrogation represents Ambac’s estimate of subrogation recoveries from RMBS transaction sponsors for R&W breaches. |
(3) | Other subrogation represents subrogation related to excess spread and other contractual cash flows on public finance and structured finance transactions, including RMBS. |
(4) | Reinsurance recoverable reported on the Balance Sheet includes reinsurance recoverables of $ |
Surveillance Categories as of December 31, 2019 | |||||||||||||||||||||||||||
I | IA | II | III | IV | V | Total | |||||||||||||||||||||
Number of policies | |||||||||||||||||||||||||||
Remaining weighted-average contract period (in years) (1) | |||||||||||||||||||||||||||
Gross insured contractual payments outstanding: | |||||||||||||||||||||||||||
Principal | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Interest | |||||||||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Gross undiscounted claim liability | $ | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
Discount, gross claim liability | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||
Gross claim liability before all subrogation and before reinsurance | |||||||||||||||||||||||||||
Less: | |||||||||||||||||||||||||||
Gross RMBS subrogation (2) | ( | ) | ( | ) | |||||||||||||||||||||||
Discount, RMBS subrogation | |||||||||||||||||||||||||||
Discounted RMBS subrogation, before reinsurance | ( | ) | ( | ) | |||||||||||||||||||||||
Less: | |||||||||||||||||||||||||||
Gross other subrogation (3) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||
Discount, other subrogation | |||||||||||||||||||||||||||
Discounted other subrogation, before reinsurance | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||
Gross claim liability, net of all subrogation and discounts, before reinsurance | ( | ) | ( | ) | |||||||||||||||||||||||
Less: Unearned premium revenue | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||
Plus: Loss expense reserves | |||||||||||||||||||||||||||
Gross loss and loss expense reserves | $ | $ | $ | $ | $ | ( | ) | $ | $ | ( | ) | ||||||||||||||||
Reinsurance recoverable reported on Balance Sheet (4) | $ | $ | $ | $ | $ | ( | ) | $ | $ | ||||||||||||||||||
(1) | Remaining weighted-average contract period is weighted based on projected gross claims over the lives of the respective policies. |
(2) | RMBS subrogation represents Ambac’s estimate of subrogation recoveries from RMBS transaction sponsors for R&W breaches. |
(3) | Other subrogation represents subrogation related to excess spread and other contractual cash flows on public finance and structured finance transactions, including RMBS. |
(4) | Reinsurance recoverable reported on Balance Sheet includes reinsurance recoverables of $ |
Six Months Ended June 30, | |||||||
2020 | 2019 | ||||||
Discounted R&W subrogation (gross of reinsurance) at beginning of period | $ | $ | |||||
All other changes (1) | ( | ) | |||||
Discounted R&W subrogation (gross of reinsurance) at end of period | $ | $ | |||||
(1) | All other changes which may impact RMBS R&W subrogation recoveries include changes in actual or projected collateral performance, changes in the creditworthiness of a sponsor and/or the projected timing of recoveries. |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Insurance amortization expense | $ | $ | $ | $ | ||||||||||||
June 30, 2020 | December 31, 2019 | |||||||
Gross carrying value of insurance intangible asset | $ | $ | ||||||
Accumulated amortization of insurance intangible asset | ||||||||
Net insurance intangible asset | $ | $ | ||||||
Amortization expense (1) (2) | ||||
2020 (six months) | $ | |||
2021 | ||||
2022 | ||||
2023 | ||||
2024 | ||||
Thereafter | ||||
(1) | The insurance intangible asset will be amortized using a level-yield method based on par exposure of the related financial guarantee insurance or reinsurance contracts. Future amortization considers the use of contractual lives for many bond types which do not have homogeneous pools of underlying collateral. Actual maturities will differ from contractual maturities because borrowers may have the right to call or prepay certain obligations. If those bonds types are retired early, amortization expense may differ in the period of call or refinancing. |
(2) | The weighted-average amortizations period is |
l | Level 1 | Quoted prices for identical instruments in active markets. Assets and liabilities classified as Level 1 include US Treasury and other foreign government obligations traded in highly liquid and transparent markets, certain highly liquid pooled fund investments, exchange traded futures contracts, variable rate demand obligations and money market funds. | |
l | Level 2 | Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Assets and liabilities classified as Level 2 generally include investments in fixed income securities representing municipal, asset-backed and corporate obligations, certain interest rate swap contracts and most long-term debt of variable interest entities consolidated under the Consolidation Topic of the ASC. | |
l | Level 3 | Model derived valuations in which one or more significant inputs or significant value drivers are unobservable. This hierarchy requires the use of observable market data when available. Assets and liabilities classified as Level 3 include credit derivative contracts, certain uncollateralized interest rate swap contracts, equity interests in Ambac sponsored special purpose entities and certain investments in fixed income securities. Additionally, Level 3 assets and liabilities generally include loan receivables, and certain long-term debt of variable interest entities consolidated under the Consolidation Topic of the ASC. | |
Carrying Amount | Total Fair Value | Fair Value Measurements Categorized as: | ||||||||||||||||||
June 30, 2020: | Level 1 | Level 2 | Level 3 | |||||||||||||||||
Financial assets: | ||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||
Municipal obligations | $ | $ | $ | $ | $ | |||||||||||||||
Corporate obligations | ||||||||||||||||||||
Foreign obligations | ||||||||||||||||||||
U.S. government obligations | ||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||
Collateralized debt obligations | ||||||||||||||||||||
Other asset-backed securities | ||||||||||||||||||||
Fixed income securities, pledged as collateral: | ||||||||||||||||||||
Short-term | ||||||||||||||||||||
Short term investments | ||||||||||||||||||||
Other investments (1) | ||||||||||||||||||||
Cash, cash equivalents and restricted cash | ||||||||||||||||||||
Derivative assets: | ||||||||||||||||||||
Interest rate swaps—asset position | ||||||||||||||||||||
Other assets - equity in sponsored VIE | ||||||||||||||||||||
Other assets-Loans | ||||||||||||||||||||
Variable interest entity assets: | ||||||||||||||||||||
Fixed income securities: Corporate obligations | ||||||||||||||||||||
Fixed income securities: Municipal obligations | ||||||||||||||||||||
Restricted cash | ||||||||||||||||||||
Loans | ||||||||||||||||||||
Derivative assets: Currency swaps-asset position | ||||||||||||||||||||
Total financial assets | $ | $ | $ | $ | $ | |||||||||||||||
Financial liabilities: | ||||||||||||||||||||
Long term debt, including accrued interest | $ | $ | $ | $ | $ | |||||||||||||||
Derivative liabilities: | ||||||||||||||||||||
Credit derivatives | ||||||||||||||||||||
Interest rate swaps—liability position | ||||||||||||||||||||
Liabilities for net financial guarantees written (2) | ( | ) | ||||||||||||||||||
Variable interest entity liabilities: | ||||||||||||||||||||
Long-term debt (includes $3,953 at fair value) | ||||||||||||||||||||
Derivative liabilities: Interest rate swaps—liability position | ||||||||||||||||||||
Total financial liabilities | $ | $ | $ | $ | $ | |||||||||||||||
Carrying Amount | Total Fair Value | Fair Value Measurements Categorized as: | ||||||||||||||||||
December 31, 2019: | Level 1 | Level 2 | Level 3 | |||||||||||||||||
Financial assets: | ||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||
Municipal obligations | $ | $ | $ | $ | $ | |||||||||||||||
Corporate obligations | ||||||||||||||||||||
Foreign obligations | ||||||||||||||||||||
U.S. government obligations | ||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||
Collateralized debt obligations | ||||||||||||||||||||
Other asset-backed securities | ||||||||||||||||||||
Fixed income securities, pledged as collateral: | ||||||||||||||||||||
Short-term | ||||||||||||||||||||
Short term investments | ||||||||||||||||||||
Other investments (1) | ||||||||||||||||||||
Cash and cash equivalents and restricted cash | ||||||||||||||||||||
Derivative assets: | ||||||||||||||||||||
Interest rate swaps—asset position | ||||||||||||||||||||
Other assets - equity in sponsored VIE | ||||||||||||||||||||
Other assets-loans | ||||||||||||||||||||
Variable interest entity assets: | ||||||||||||||||||||
Fixed income securities: Corporate obligations | ||||||||||||||||||||
Fixed income securities: Municipal obligations | ||||||||||||||||||||
Restricted cash | ||||||||||||||||||||
Loans | ||||||||||||||||||||
Derivative assets: Currency swaps—asset position | ||||||||||||||||||||
Total financial assets | $ | $ | $ | $ | $ | |||||||||||||||
Financial liabilities: | ||||||||||||||||||||
Long term debt, including accrued interest | $ | $ | $ | $ | $ | |||||||||||||||
Derivative liabilities: | ||||||||||||||||||||
Interest rate swaps—liability position | ||||||||||||||||||||
Liabilities for net financial guarantees written (2) | ( | ) | ||||||||||||||||||
Variable interest entity liabilities: | ||||||||||||||||||||
Long-term debt (includes $4,351 at fair value) | ||||||||||||||||||||
Derivative liabilities: Interest rate swaps—liability position | ||||||||||||||||||||
Total financial liabilities | $ | $ | $ | $ | $ | |||||||||||||||
(1) | Excluded from the fair value measurement categories in the table above are investment funds of $ |
(2) | The carrying value of net financial guarantees written includes the following balance sheet items: Premium receivables; Reinsurance recoverable on paid and unpaid losses; Deferred ceded premium; Subrogation recoverable; Insurance intangible asset; Unearned premiums; Loss and loss expense reserves; Ceded premiums payable, premiums taxes payable and other deferred fees recorded in Other liabilities. |
June 30, 2020: | |
a. Coupon rate: | |
b. Average Life: | |
c. Yield: | |
December 31, 2019: | |
a. Coupon rate: | |
b. Average Life: | |
c. Yield: | |
Level 3 - Financial Assets and Liabilities Accounted for at Fair Value | ||||||||||||||||||||||||||||
VIE Assets and Liabilities | ||||||||||||||||||||||||||||
Investments | Other Assets(1) | Derivatives | Investments | Loans | Long-term Debt | Total | ||||||||||||||||||||||
Three Months Ended June 30, 2020: | ||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Total gains/(losses) realized and unrealized: | ||||||||||||||||||||||||||||
Included in earnings | ( | ) | ||||||||||||||||||||||||||
Included in other comprehensive income | — | — | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||
Purchases | — | — | — | — | — | — | — | |||||||||||||||||||||
Issuances | — | — | — | — | — | — | — | |||||||||||||||||||||
Sales | — | — | — | — | — | — | — | |||||||||||||||||||||
Settlements | — | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
The amount of total gains/(losses) included in earnings attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | — | $ | $ | $ | $ | ( | ) | $ | $ | ||||||||||||||||||
The amount of total gains/(losses) included in other comprehensive income attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | |||||||||||||||
Three Months Ended June 30, 2019: | ||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
Total gains/(losses) realized and unrealized: | ||||||||||||||||||||||||||||
Included in earnings | ( | ) | ||||||||||||||||||||||||||
Included in other comprehensive income | — | — | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||
Purchases | — | — | — | — | — | — | — | |||||||||||||||||||||
Issuances | — | — | — | — | — | — | — | |||||||||||||||||||||
Sales | — | — | — | — | — | — | — | |||||||||||||||||||||
Settlements | — | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
The amount of total gains/(losses) included in earnings attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | — | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||||
(1) | Other assets carried at fair value and classified as Level 3 relate to an equity interest in an Ambac sponsored VIE. |
Level 3 - Financial Assets and Liabilities Accounted for at Fair Value | ||||||||||||||||||||||||||||
VIE Assets and Liabilities | ||||||||||||||||||||||||||||
Investments | Other Assets | Derivatives | Investments | Loans | Long-term Debt | Total | ||||||||||||||||||||||
Six Months Ended June 30, 2020: | ||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
Total gains/(losses) realized and unrealized: | ||||||||||||||||||||||||||||
Included in earnings | ( | ) | ||||||||||||||||||||||||||
Included in other comprehensive income | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||
Purchases | ||||||||||||||||||||||||||||
Issuances | ||||||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||||||
Settlements | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | $ | |||||||||||||||||||||
The amount of total gains/(losses) included in earnings attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | $ | ( | ) | $ | $ | $ | $ | $ | |||||||||||||||||||
The amount of total gains/(losses) included in other comprehensive income attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | ( | ) | $ | $ | $ | ( | ) | $ | ( | ) | $ | $ | ( | ) | |||||||||||||
Six Months Ended June 30, 2019: | ||||||||||||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
Total gains/(losses) realized and unrealized: | ||||||||||||||||||||||||||||
Included in earnings | ( | ) | ( | ) | ||||||||||||||||||||||||
Included in other comprehensive income | ( | ) | ( | ) | ( | ) | ||||||||||||||||||||||
Purchases | ||||||||||||||||||||||||||||
Issuances | ||||||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||||||
Settlements | ( | ) | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||||
Balance, end of period | $ | $ | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||||
The amount of total gains/(losses) included in earnings attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | $ | ( | ) | $ | $ | $ | $ | ( | ) | $ | |||||||||||||||||
Level 3 - Derivatives by Class: | ||||||||||||||||||||||||
Three Months Ended June 30, 2020 | Three Months Ended June 30, 2019 | |||||||||||||||||||||||
Interest Rate Swaps | Credit Derivatives | Total Derivatives | Interest Rate Swaps | Credit Derivatives | Total Derivatives | |||||||||||||||||||
Balance, beginning of period | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||
Total gains/(losses) realized and unrealized: | ||||||||||||||||||||||||
Included in earnings | ||||||||||||||||||||||||
Included in other comprehensive income | ||||||||||||||||||||||||
Purchases | ||||||||||||||||||||||||
Issuances | ||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||
Settlements | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Balance, end of period | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||
The amount of total gains/(losses) included in earnings attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Level 3 - Derivatives by Class: | ||||||||||||||||||||||||
Six Months Ended June 30, 2020 | Six Months Ended June 30, 2019 | |||||||||||||||||||||||
Interest Rate Swaps | Credit Derivatives | Total Derivatives | Interest Rate Swaps | Credit Derivatives | Total Derivatives | |||||||||||||||||||
Balance, beginning of period | $ | $ | $ | $ | $ | ( | ) | $ | ||||||||||||||||
Total gains/(losses) realized and unrealized: | ||||||||||||||||||||||||
Included in earnings | ( | ) | ||||||||||||||||||||||
Included in other comprehensive income | ||||||||||||||||||||||||
Purchases | ||||||||||||||||||||||||
Issuances | ||||||||||||||||||||||||
Sales | ||||||||||||||||||||||||
Settlements | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||||||||
Balance, end of period | $ | $ | ( | ) | $ | $ | $ | ( | ) | $ | ||||||||||||||
The amount of total gains/(losses) included in earnings attributable to the change in unrealized gains or losses relating to assets and liabilities still held at the reporting date | $ | $ | ( | ) | $ | $ | $ | $ | ||||||||||||||||
Net Investment Income | Net Gains (Losses) on Derivative Contracts | Income (Loss) on Variable Interest Entities | Other Income or (Loss) | |||||||||||||
Three Months Ended June 30, 2020: | ||||||||||||||||
Total gains or losses included in earnings for the period | $ | $ | $ | $ | ||||||||||||
Changes in unrealized gains or losses included in earnings relating to the assets and liabilities still held at the reporting date | ||||||||||||||||
Three Months Ended June 30, 2019: | ||||||||||||||||
Total gains or losses included in earnings for the period | $ | $ | $ | $ | ||||||||||||
Changes in unrealized gains or losses included in earnings relating to the assets and liabilities still held at the reporting date | ||||||||||||||||
Six Months Ended June 30, 2020: | ||||||||||||||||
Total gains or losses included in earnings for the period | $ | $ | $ | $ | ( | ) | ||||||||||
Changes in unrealized gains or losses relating to the assets and liabilities still held at the reporting date | ( | ) | ||||||||||||||
Six Months Ended June 30, 2019: | ||||||||||||||||
Total gains or losses included in earnings for the period | ( | ) | ||||||||||||||
Changes in unrealized gains or losses relating to the assets and liabilities still held at the reporting date | ( | ) | ||||||||||||||
Amortized Cost | Allowance for Credit Losses | Gross Unrealized Gains in AOCI | Gross Unrealized Losses in AOCI | Estimated Fair Value | ||||||||||||||||
June 30, 2020: | ||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||
Municipal obligations | $ | $ | $ | $ | $ | |||||||||||||||
Corporate obligations (1) | ||||||||||||||||||||
Foreign obligations | ||||||||||||||||||||
U.S. government obligations | ||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||
Collateralized debt obligations | ||||||||||||||||||||
Other asset-backed securities | ||||||||||||||||||||
Short-term | ||||||||||||||||||||
Fixed income securities pledged as collateral: | ||||||||||||||||||||
Short-term | ||||||||||||||||||||
Total collateralized investments | ||||||||||||||||||||
Total available-for-sale investments | $ | $ | $ | $ | $ | |||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | Non-credit Other-than temporary Impairments (2) | ||||||||||||||||
December 31, 2019: | ||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||
Municipal obligations | $ | $ | $ | $ | $ | |||||||||||||||
Corporate obligations (1) | ||||||||||||||||||||
Foreign obligations | ||||||||||||||||||||
U.S. government obligations | ||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||
Collateralized debt obligations | ||||||||||||||||||||
Other asset-backed securities | ||||||||||||||||||||
Short-term | ||||||||||||||||||||
Fixed income securities pledged as collateral: | ||||||||||||||||||||
Short-term | ||||||||||||||||||||
Total collateralized investments | ||||||||||||||||||||
Total available-for-sale investments | $ | $ | $ | $ | $ | |||||||||||||||
(1) | Includes Ambac's holdings of the secured notes issued by Ambac LSNI in connection with the Rehabilitation Exit Transactions. |
(2) | At December 31, 2019, represents the amount of non-credit other-than-temporary impairment losses remaining in accumulated other comprehensive income on securities that also had a credit impairment. These losses are included in gross unrealized losses at December 31, 2019. |
Amortized Cost | Estimated Fair Value | |||||||
Due in one year or less | $ | $ | ||||||
Due after one year through five years | ||||||||
Due after five years through ten years | ||||||||
Due after ten years | ||||||||
Residential mortgage-backed securities | ||||||||
Collateralized debt obligations | ||||||||
Other asset-backed securities | ||||||||
Total | $ | $ | ||||||
Less Than 12 Months | 12 Months or More | Total | ||||||||||||||||||||||
Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | |||||||||||||||||||
June 30, 2020: | ||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||
Municipal obligations | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Corporate obligations | ||||||||||||||||||||||||
U.S. government obligations | ||||||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||||||
Collateralized debt obligations | ||||||||||||||||||||||||
Other asset-backed securities | ||||||||||||||||||||||||
Short-term | ||||||||||||||||||||||||
Total securities | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Less Than 12 Months | 12 Months or More | Total | ||||||||||||||||||||||
Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | Fair Value | Gross Unrealized Loss | |||||||||||||||||||
December 31, 2019: | ||||||||||||||||||||||||
Fixed income securities: | ||||||||||||||||||||||||
Municipal obligations | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Corporate obligations | ||||||||||||||||||||||||
Foreign obligations | ||||||||||||||||||||||||
U.S. government obligations | ||||||||||||||||||||||||
Residential mortgage-backed securities | ||||||||||||||||||||||||
Commercial mortgage-backed securities | ||||||||||||||||||||||||
Collateralized debt obligations | ||||||||||||||||||||||||
Other asset-backed securities | ||||||||||||||||||||||||
Short-term | ||||||||||||||||||||||||
Total securities | $ | $ | $ | $ | $ | $ | ||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Gross realized gains on securities | $ | $ | $ | $ | ||||||||||||
Gross realized losses on securities | ( | ) | ( | ) | ( | ) | ||||||||||
Net foreign exchange (losses) gains | ||||||||||||||||
Credit impairments (1) | ||||||||||||||||
Intent / requirement to sell impairments (2) | ||||||||||||||||
Net realized gains (losses) | $ | $ | $ | $ | ||||||||||||
(1) | Includes securities which management does not intend to sell and it is not more likely than not that the Company will be required to sell before recovery of the amortized cost basis. |
(2) | Includes securities which management either intends sell or it is more likely than not that the Company will be required to sell before recovery of the amortized cost basis. |
Balance, beginning of period | $ | |||
Reductions for credit impairments previously recognized on: | ||||
Securities that matured or were sold during the period | ( | ) | ||
Balance, end of period | $ | |||
Municipal Obligations | Corporate Obligations (2) | Mortgage and Asset- backed Securities | Total | Weighted Average Underlying Rating (1) | ||||||||||||||
June 30, 2020: | ||||||||||||||||||
Ambac Assurance Corporation | $ | $ | $ | $ | CCC+ | |||||||||||||
National Public Finance Guarantee Corporation | — | BBB- | ||||||||||||||||
Total | $ | $ | $ | $ | B- | |||||||||||||
December 31, 2019: | ||||||||||||||||||
Ambac Assurance Corporation | $ | $ | $ | $ | B- | |||||||||||||
National Public Finance Guarantee Corporation | — | BBB- | ||||||||||||||||
Total | $ | $ | $ | $ | B- | |||||||||||||
(1) | Ratings are based on the lower of Standard & Poor’s or Moody’s rating. If unavailable, Ambac’s internal rating is used. |
(2) | Represents Ambac's holdings of secured notes issued by Ambac LSNI in connection with the Rehabilitation Exit Transactions. These secured notes are insured by Ambac Assurance. |
Fair Value | ||||||||||||
Class of Funds | June 30, 2020 | December 31, 2019 | Redemption Frequency | Redemption Notice Period | ||||||||
Real estate properties (1) | $ | $ | quarterly | 10 business days | ||||||||
Hedge funds (2) | quarterly | 90 days | ||||||||||
High yields and leveraged loans (3) (10) | daily | 0 - 30 days | ||||||||||
Private credit (4) | quarterly | 180 days if permitted | ||||||||||
Insurance-linked investments (5) | fully redeemed | none | ||||||||||
Equity market investments (6) (10) | daily | 0 days | ||||||||||
Investment grade floating rate income (7) | weekly | 0 days | ||||||||||
Private equity (8) | quarterly | 90 days if permitted | ||||||||||
Emerging markets debt (9) (10) | daily | 0 days | ||||||||||
Total equity investments in pooled funds | $ | $ | ||||||||||
(1) | Investments consist of UK property to generate income and capital growth. |
(2) | This class seeks to generate superior risk-adjusted returns through selective asset sourcing, active trading and hedging strategies within structured credit markets, including mortgage-backed securities, commercial real estate securities and loans, CLOs, REITs and asset backed securities. |
(3) | This class of funds includes investments in a range of instruments including high-yield bonds, leveraged loans, CLOs, ABS and floating rate notes to generate income and capital appreciation. |
(4) | This class aims to obtain high long-term return primarily through credit and preferred equity investments with low liquidity and defined term. |
(5) | This class seeks to generate returns from insurance markets through investments in catastrophe bonds, life insurance and other insurance linked investments. |
(6) | This class of funds aim to achieve long term growth through diversified exposure to global equity markets. |
(7) | This class of funds includes investments in high quality floating rate debt securities including ABS and corporate floating rate notes as well as ultra-short term bonds and money market instruments. |
(8) | This class seeks to generate long-term capital appreciation through investments in private equity, equity-related and other instruments. |
(9) | This class seeks long-term income and growth through investments in the bonds of issuers in emerging markets. |
(10) | These categories include fair value amounts totaling $ |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Fixed income securities | $ | $ | $ | $ | ||||||||||||
Short-term investments | ||||||||||||||||
Investment expense | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||
Securities available-for-sale and short-term | ||||||||||||||||
Other investments | ( | ) | ||||||||||||||
Total net investment income (loss) | $ | $ | $ | $ | ||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | 2020 | 2019 | |||||||||||||
Net gains (losses) recognized during the period on trading securities | $ | $ | $ | ( | ) | $ | ||||||||||
Less: net gains (losses) recognized during the reporting period on trading securities sold during the period | ( | ) | ||||||||||||||
Unrealized gains (losses) recognized during the reporting period on trading securities still held at the reporting date | $ | $ | $ | $ | ||||||||||||
Gross Amounts of Recognized Assets / Liabilities | Gross Amounts Offset in the Consolidated Balance Sheet | Net Amounts of Assets/ Liabilities Presented in the Consolidated Balance Sheet | Gross Amount of Collateral Received / Pledged Not Offset in the Consolidated Balance Sheet | Net Amount | |||||||||||||||
June 30, 2020: | |||||||||||||||||||
Derivative Assets: | |||||||||||||||||||
Interest rate swaps | $ | $ | $ | $ | — | $ | |||||||||||||
Total non-VIE derivative assets | $ | $ | $ | $ | $ | ||||||||||||||
Derivative Liabilities: | |||||||||||||||||||
Credit derivatives | $ | $ | $ | $ | — | $ | |||||||||||||
Interest rate swaps | |||||||||||||||||||
Total non-VIE derivative liabilities | $ | $ | $ | $ | $ | ||||||||||||||
Variable Interest Entities Derivative Assets: | |||||||||||||||||||
Currency swaps | $ | $ | $ | $ | — | $ | |||||||||||||
Total VIE derivative assets | $ | $ | $ | $ | $ | ||||||||||||||
Variable Interest Entities Derivative Liabilities: | |||||||||||||||||||
Interest rate swaps | $ | $ | — | $ | $ | — | $ | ||||||||||||
Total VIE derivative liabilities | $ | $ | $ | $ | $ | ||||||||||||||
December 31, 2019: | |||||||||||||||||||
Derivative Assets: | |||||||||||||||||||
Interest rate swaps | $ | $ | $ | $ | $ | ||||||||||||||
Total non-VIE derivative assets | $ | $ | $ | $ | $ | ||||||||||||||
Derivative Liabilities: | |||||||||||||||||||
Credit derivatives | $ | $ | $ | $ | — | $ | |||||||||||||
Interest rate swaps | |||||||||||||||||||
Total non-VIE derivative liabilities | $ | $ | $ | $ | $ | ||||||||||||||
Variable Interest Entities Derivative Assets: | |||||||||||||||||||
Currency swaps | $ | $ | — | $ | $ | $ | |||||||||||||
Total VIE derivative assets | $ | $ | $ | $ | $ | ||||||||||||||
Variable Interest Entities Derivative Liabilities: | |||||||||||||||||||
Interest rate swaps | $ | $ | — | $ | $ | — | $ | ||||||||||||
Total VIE derivative liabilities | $ | $ | $ | $ | $ | ||||||||||||||
Location of Gain or (Loss) Recognized in Consolidated Statements of Total Comprehensive Income (Loss) | Amount of Gain or (Loss) Recognized in Consolidated Statement of Total Comprehensive Income (Loss) | ||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||||||
Non-VIE derivatives: | |||||||||||||||||||
Credit derivatives | Net gains (losses) on derivative contracts | $ | $ | $ | ( | ) | $ | ||||||||||||
Interest rate swaps | Net gains (losses) on derivative contracts | ( | ) | ( | ) | ( | ) | ||||||||||||
Futures contracts | Net gains (losses) on derivative contracts | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
Total Non-VIE derivatives | $ | $ | ( | ) | ( | ) | ( | ) | |||||||||||
Variable Interest Entities: | |||||||||||||||||||
Currency swaps | Income (loss) on variable interest entities | $ | $ | ( | ) | ||||||||||||||
Interest rate swaps | Income (loss) on variable interest entities | ( | ) | ( | ) | ( | ) | ( | ) | ||||||||||
Total Variable Interest Entities | ( | ) | ( | ) | ( | ) | ( | ) | |||||||||||
Total derivative contracts | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||||||
Notional | ||||||||
Type of Derivative | June 30, 2020 | December 31, 2019 | ||||||
Interest rate swaps—receive-fixed/pay-variable | $ | $ | ||||||
Interest rate swaps—pay-fixed/receive-variable | ||||||||
US Treasury futures contracts—short | ||||||||
Notional | ||||||||
Type of VIE Derivative | June 30, 2020 | December 31, 2019 | ||||||
Interest rate swaps—receive-fixed/pay-variable | $ | $ | ||||||
Interest rate swaps—pay-fixed/receive-variable | ||||||||
Currency swaps | ||||||||
Credit derivatives | ||||||||
Jurisdiction | Tax Year |
United States | 2010 |
New York State | 2013 |
New York City | 2015 |
United Kingdom | 2016 |
Italy | 2015 |
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
U.S. | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||
Foreign | ( | ) | ( | ) | ( | ) | |||||||||
Total | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | |||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
2020 | 2019 | 2020 | 2019 | ||||||||||||
Current taxes | |||||||||||||||
U. S. federal | $ | $ | $ | $ | |||||||||||
U.S. state and local | ( | ) | |||||||||||||
Foreign | |||||||||||||||
Current taxes | |||||||||||||||
Deferred taxes | |||||||||||||||
Foreign | ( | ) | ( | ) | ( | ) | |||||||||
Deferred taxes | ( | ) | ( | ) | ( | ) | |||||||||
Provision for income taxes | $ | $ | $ | ( | ) | $ | |||||||||
NOL Usage Tier | Allocated NOLs | Applicable Percentage | ||
A | The first | $ | ||
B | The next | $ | after Tier A | |
C | The next | $ | after Tier B | |
D | The next | $ | after Tier C | |
• | Ambac Assurance Corporation and The Segregated Account of Ambac Assurance Corporation v. Countrywide Securities Corp., Countrywide Financial Corp. (a.k.a. Bank of America Home Loans) and Bank of America Corp. (Supreme Court of the State of New York, County of New York, Case No. 651612/2010, filed on September 28, 2010). Ambac Assurance’s Second Amended Complaint, filed on May 28, 2013, asserted claims against Countrywide and Bank of America (as successor to Countrywide’s liabilities) for, among other things, breach of contract and fraudulent inducement. In August and October 2018, Defendants filed various pre-trial motions. On December 30, 2018, the court denied all of these pre-trial motions in their entirety and Defendants appealed. On September 17, 2019, the First Department affirmed in part and reversed in part the trial court’s rulings. On October 17, 2019, Countrywide filed a motion for leave to appeal certain issues to the New York Court of Appeals and for reargument or leave to appeal certain other issues. On January 16, 2020, the First Department recalled and vacated its September 17, 2019 decision and order and substituted a new decision and order. |
• | Ambac Assurance Corporation v. U.S. Bank National Association (United States District Court, Southern District of New York, Docket No. 18-cv-5182 (LGS), filed June 8, 2018 (the “SDNY Action”)); In the matter of HarborView Mortgage Loan Trust 2005-10 (Minnesota state court, Docket No. 27-TR-CV-17-32 (the “Minnesota Action”)). These two actions relate to U.S. Bank National Association’s (“U.S. Bank”) acceptance of a proposed settlement in a separate litigation that U.S. Bank is prosecuting, as trustee, related to the Harborview Mortgage Loan Trust, Series 2005-10 (“Harborview 2005-10”), a residential mortgage-backed securitization for which Ambac Assurance issued an insurance policy. On March 6, 2017, U.S. Bank filed a petition commencing the Minnesota Action, a trust instruction proceeding in Minnesota state court concerning the proposed settlement, and on June 12, 2017, U.S. Bank filed an amended petition. Ambac Assurance filed a motion to dismiss the Minnesota Action, which was denied on November 13, 2017, and the denial was affirmed on appeal. On September 6, 2018, U.S. Bank filed its Second Amended Petition, and Ambac Assurance and certain other certificateholders objected to, or otherwise responded to, the petition. Discovery in the Minnesota Action is ongoing, and the court has set October 14, 2020 as the date for the start of the trial. On June 8, 2018, Ambac Assurance filed the SDNY Action asserting claims arising out of U.S. Bank’s acceptance of the proposed settlement and treatment of trust recoveries. Ambac Assurance asserted claims for declaratory judgment, breach of contract, and breach of fiduciary duty. On July 16, 2019, the court dismissed Ambac Assurance's breach-of-contract and breach-of-fiduciary-duty claims based on U.S. Bank's acceptance of the settlement; and dismissed Ambac Assurance's declaratory judgment claims regarding the occurrence of an Event of Default and U.S. Bank's future distribution of trust recoveries through the waterfall. The court denied the motion to dismiss Ambac Assurance's breach-of-contract claims based on U.S. Bank's past distribution of trust recoveries through the waterfall. On January 17, 2020, U.S. Bank moved for summary judgment regarding the remaining claim relating to distributions. On February 7, 2020, Ambac Assurance cross-moved for summary judgment. These summary judgment motions are fully briefed. |
• | In re application of Deutsche Bank National Trust Company as Trustee of the Harborview Mortgage Loan Trust Mortgage Loan Pass-Through Certificates, Series 2006-9 (Supreme Court of the State of New York, County of New York, No. 654208/2018), filed August 23, 2018 (the “Trust Instruction |
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | A commutation in January 2020, via a refunding, of a watch list public finance transaction with net par outstanding of $171 million at December 31, 2019; |
• | A refinancing in February 2020 of an adversely classified asset-backed leasing transaction with net par outstanding of $86 million at December 31, 2019; and |
• | Purchasing quota share reinsurance in June 2020 on a transportation revenue credit with net par outstanding of $33 million at December 31, 2019. |
($ in millions) | June 30, 2020 | December 31, 2019 | Variance | |||||||||||
Total | $ | 35,276 | $ | 38,018 | $ | (2,742 | ) | (7 | )% | |||||
ACC | 8,756 | 7,535 | 1,221 | 16 | % | |||||||||
Watch list | 5,238 | 6,752 | (1,514 | ) | (22 | )% | ||||||||
• | Ambac’s insurance policies will be drawn in the event that the issuers of insured obligations do not make payments on their obligations when due. As a result of the COVID-19 related economic impact on issuers and markets where Ambac provides financial guarantees; including lower tax, project, and business revenues and increases in forbearances or delinquencies on mortgage and student loan payments, we have increased our loss reserves and may further increase them in the future depending on the duration and severity of the crisis. The crisis may also impair certain issuers' ability to pay premiums owed to Ambac; however, we believe such issuers currently have the ability to continue to pay such premiums timely, but this is subject to change. |
• | Ambac has exposure to reinsurance counterparties for their portions of future claim payments. Ambac has reinsured approximately 13.5% of its gross par outstanding to four reinsurance counterparties. Each of these reinsurance counterparties is experienced in the business of reinsuring and/or writing financial guaranty insurance. All have current ratings of A+ (by S&P) or better and have sufficient collateralization or replacement triggers upon downgrade. Ambac actively monitors each of these reinsurance entities and currently believes they have the ability to perform under their respective reinsurance policies, but this is subject to change. |
• | Ambac is exposed to the risk that contractual counterparties (including those under our RMBS litigations and derivative counterparties) may default in their financial obligations, whether as the result of insolvency, lack of liquidity, operational failure, fraud or other reasons. At present, Ambac has no concerns about the ability of our contractual counterparties, which include certain regulated exchanges in the case of interest rate swaps and futures, to perform under their contracts, but this is subject to change. |
• | Asset prices declined substantially during the first quarter, particularly in directly affected industries such as tourism, airlines, hospitality, commercial real estate and manufacturing. While Ambac does not have significant investments in these asset classes, we did experience a negative total return for the investment portfolio of approximately (4.4)% during the three month period ending March 31, 2020. We evaluated and did not recognize credit impairments on the investment portfolio as of such date. However, in early April 2020, we monetized a material portion of our investments in certain assets classes; including corporate securities rated below the 'A' rated category, all directly owned CMBS (other than Military Housing bonds), and approximately 50% of all CLOs (all rated investment grade). While these positions were sold at a net gain, future investment losses and impairments may be possible. Asset prices partially recovered during the second quarter of 2020. Ambac recognized a total return for the investment portfolio of approximately 4.7% during the three months ended June 30, 2020. |
($ in millions) | ||||
Cash and short-term investments | $ | 328 | ||
Other investments (1) | 116 | |||
Other net assets (2) | 37 | |||
Total | $ | 481 | ||
(1) | Includes surplus notes (fair value of $57 million) issued by Ambac Assurance that are eliminated in consolidation. |
(2) | Includes accruals for tolling payments from Ambac Assurance in accordance with the Amended Tax Sharing Agreement of $28 million. Refer to Note 10. Income Taxes for discussion over the timing of collection. |
($ in millions) | ||||
Net income (1) | $ | 3 | ||
Gain (loss) on foreign currency translation (net of tax) | (48 | ) | ||
Unrealized gains (losses) on non-functional currency available-for-sale securities (net of tax) | 11 | |||
Impact on total comprehensive income (loss) | $ | (34 | ) | |
(1) | A portion of Ambac UK's, and to a lesser extent Ambac Assurance's, assets and liabilities are denominated in currencies other than its functional currency and accordingly, we recognized net foreign currency transaction gains/(losses) as a result of changes to foreign currency rates through our Unaudited Consolidated Statement of Total Comprehensive Income (Loss). Refer to Note 2. Basis of Presentation and Significant Accounting Policies to the Unaudited |
($ in millions) | June 30, 2020 | December 31, 2019 | |||||
Public Finance (1) (2) | $ | 16,473 | $ | 17,653 | |||
Structured Finance | 6,877 | 7,508 | |||||
International Finance | 11,926 | 12,857 | |||||
Total net par outstanding | $ | 35,276 | $ | 38,018 | |||
(1) | Includes $5,615 and $5,654 of Military Housing net par outstanding at June 30, 2020 and December 31, 2019, respectively. |
(2) | Includes $1,105 and $1,123 of Puerto Rico net par outstanding at June 30, 2020 and December 31, 2019, respectively. Components of Puerto Rico net par outstanding include capital appreciation bonds which are reported at the par amount at the time of issuance of the related insurance policy as opposed to the current accreted value of the bonds. |
($ in millions) | Risk Name | Country-Bond Type | Ambac Ratings (1) | Net Par Outstanding (2) | % of Total Net Par Outstanding | ||||||||
IF | AUK | Mitchells & Butlers Finance plc-UK Pub Securitisation | UK-Asset Securitizations | BBB | $ | 938 | 2.7 | % | |||||
IF | AUK | Capital Hospitals plc (3) | UK-Infrastructure | A- | 828 | 2.3 | % | ||||||
IF | AUK | Aspire Defence Finance plc | UK-Infrastructure | A- | 799 | 2.3 | % | ||||||
PF | AAC | New Jersey Transportation Trust Fund Authority - Transportation System | US-Lease and Tax-backed Revenue | BBB- | 772 | 2.2 | % | ||||||
IF | AUK | Anglian Water | UK-Utility | A- | 770 | 2.2 | % | ||||||
IF | AUK | National Grid Gas | UK-Utility | A- | 711 | 2.0 | % | ||||||
IF | AUK | Posillipo Finance II S.r.l | Italy-Sub-Sovereign | BIG | 698 | 2.0 | % | ||||||
IF | AUK | Ostregion Investmentgesellschaft NR 1 SA (3) | Austria-Infrastructure | BIG | 663 | 1.9 | % | ||||||
PF | AAC | Mets Queens Baseball Stadium Project, NY, Lease Revenue | US-Stadium Financing | BIG | 540 | 1.5 | % | ||||||
IF | AUK | RMPA Services plc | UK-Infrastructure | BBB+ | 529 | 1.5 | % | ||||||
Total | $ | 7,248 | 20.6 | % | |||||||||
PF = Public Finance, SF = Structured Finance, IF = International Finance AAC = Ambac Assurance, AUK = Ambac UK | |||||||||||||
(1) | Internal credit ratings are provided solely to indicate the underlying credit quality of guaranteed obligations based on the view of Ambac. In cases where Ambac has insured multiple tranches of an issue with varying internal ratings, or more than one obligation of an issuer with varying internal ratings, a weighted average rating is used. Ambac credit ratings are subject to revision at any time and do not constitute investment advice. BIG denotes credits deemed below investment grade. |
(2) | Net Par includes capital appreciation bonds, which are reported at the par amount at the time of issuance of the insurance policy as opposed to the current accreted value of the bonds. |
(3) | A portion of this transaction is insured by an insurance policy issued by Ambac Assurance. Ambac Assurance has issued policies for these transactions that will only pay in the event that Ambac UK does not pay under its insurance policies ("second to pay policies"). |
• | A program for direct lending, loans, loan guarantees and investments to eligible businesses, states and municipalities, including to passenger airlines and cargo airlines; |
• | A program for small business loans (Paycheck Protection Program, as amended by the Paycheck Protection Program and Health Care Enhancement Act (“PPP & HCE Act”)); |
• | Business tax breaks, including payroll tax deferral |
• | An allocation of direct aid to state and local governments to reimburse them for the costs of dealing with COVID-19; |
• | The Public Health and Social Services Fund for distribution of grants to healthcare providers and hospitals (as amended by the PPP & HCE Act); |
• | Grants for transit agencies; |
• | Grants for airport authorities; and |
• | Direct payments to households and for unemployment insurance. |
• | $500 billion for the Municipal Liquidity Facility; |
• | $750 billion for the Primary Market Corporate Credit Facility and Secondary Market Corporate Credit Facility; and |
• | $100 billion in loans for the Term Asset-backed Securities Facility |
($ in millions) Market / Sector | Total NPO | Total Debt Service Due Next Twelve Months | ||||
Hotels / Convention Centers | $ | 257 | $ | 37.3 | ||
Stadiums | 634 | 41.7 | ||||
Airports | 124 | 22.0 | ||||
Dedicated Tax | 410 | 78.0 | ||||
Higher Education Auxiliary | 252 | 26.9 | ||||
Rail / Mass Transit | 328 | 30.1 | ||||
Toll Roads / Bridges | 469 | 35.8 | ||||
Total Public Finance | $ | 2,474 | $ | 271.8 | ||
($ in millions) Market / Sector | Total NPO | Total Debt Service Due for Twelve Months | ||||
Stadiums | $ | 203 | $ | 23.6 | ||
Higher Education | 161 | 8.7 | ||||
Airports | 192 | 6.0 | ||||
Asset Securitizations | 938 | 78.9 | ||||
Toll Roads / Bridges | 719 | 57.0 | ||||
Total | $ | 2,213 | $ | 174.2 | ||
• | the fiscal and monetary policies of the federal government which will shape the trajectory of the U.S. economy; |
• | the speed and efficacy of targeted federal aid packages to (1) help Puerto Rico address the negative economic effects of the pandemic and (2) rebuild better and more resilient infrastructure post-Hurricanes Irma and Maria in 2017 and earthquakes in 2020; |
• | supplemental Medicaid funding relief; and |
• | the willingness and ability of the Commonwealth government to implement much needed fiscal and structural reforms. |
Currency (Amounts in millions) | Net Par Amount Outstanding in Base Currency | Net Par Amount Outstanding in U.S. Dollars | ||||||
U.S. Dollars | $ | 23,734 | $ | 23,734 | ||||
British Pounds | £ | 7,636 | 9,458 | |||||
Euros | € | 1,520 | 1,708 | |||||
Australian Dollars | A$ | 545 | 376 | |||||
Total | $ | 35,276 | ||||||


(1) | Internal credit ratings are provided solely to indicate the underlying credit quality of guaranteed obligations based on the view of Ambac. In cases where Ambac has insured multiple tranches of an issue with varying internal ratings, or more than one obligation of an issuer with varying internal ratings, a weighted average rating is used. Ambac credit ratings are subject to revision at any time and do not constitute investment advice. |
Net Par Outstanding | ||||||||
Summary of Below Investment Grade Exposure ($ in millions) | June 30, 2020 | December 31, 2019 | ||||||
Public Finance: | ||||||||
Lease and tax-backed (1) | $ | 1,235 | $ | 1,109 | ||||
General obligation (1) | 346 | 525 | ||||||
Housing (2) | 310 | 311 | ||||||
Stadium | 540 | — | ||||||
Transportation | 41 | 27 | ||||||
Other | 41 | 42 | ||||||
Total Public Finance | 2,513 | 2,014 | ||||||
Structured Finance: | ||||||||
RMBS | 3,081 | 3,362 | ||||||
Student loans | 566 | 620 | ||||||
Other | 10 | 33 | ||||||
Total Structured Finance | 3,657 | 4,015 | ||||||
International Finance: | ||||||||
Other | 1,480 | 1,455 | ||||||
Total International Finance | 1,480 | 1,455 | ||||||
Total | $ | 7,650 | $ | 7,484 | ||||
(1) | Lease and tax-backed revenue includes $996 and $1,014 of Puerto Rico net par at June 30, 2020 and December 31, 2019, respectively. General obligation includes $109 and $109 of Puerto Rico net par at June 30, 2020 and December 31, 2019, respectively. Components of Puerto Rico net par outstanding includes capital appreciation bonds which are reported at the par amount at the time of issuance of the related insurance policy as opposed to the current accreted value of the bonds. |
(2) | Relates to military housing net par. |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Revenues: | ||||||||||||||||
Net premiums earned | $ | 11 | $ | 8 | $ | 21 | $ | 36 | ||||||||
Net investment income | 52 | 86 | 31 | 141 | ||||||||||||
Net realized investment gains (losses) | 10 | 36 | 18 | 53 | ||||||||||||
Net gains (losses) on derivative contracts | 2 | (35 | ) | (68 | ) | (52 | ) | |||||||||
Income (loss) on variable interest entities | — | 3 | 3 | 19 | ||||||||||||
Expenses: | ||||||||||||||||
Losses and loss expenses (benefit) | 16 | (133 | ) | 132 | (121 | ) | ||||||||||
Insurance intangible amortization | 14 | 226 | 27 | 263 | ||||||||||||
Operating expenses | 21 | 29 | 44 | 54 | ||||||||||||
Interest expense | 58 | 67 | 122 | 135 | ||||||||||||
Provision for income taxes | 2 | 28 | (4 | ) | 30 | |||||||||||
Net income (loss) attributable to common stockholders | $ | (35 | ) | $ | (128 | ) | $ | (315 | ) | $ | (172 | ) | ||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Normal premiums earned | ||||||||||||||||
Public finance | $ | 5 | $ | 7 | $ | 10 | $ | 15 | ||||||||
Structured finance | 2 | 3 | 4 | 6 | ||||||||||||
International finance | 3 | 4 | 6 | 10 | ||||||||||||
Total normal premiums earned | 10 | 14 | 20 | 30 | ||||||||||||
Accelerated earnings | 1 | (6 | ) | 1 | 6 | |||||||||||
Total net premiums earned | $ | 11 | $ | 8 | $ | 21 | $ | 36 | ||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | |||||||||||
Securities available-for-sale: Ambac-insured (including Secured Notes) | $ | 16 | $ | 58 | $ | 32 | $ | 87 | |||||||
Securities available-for-sale and short-term other than Ambac-insured | 10 | 20 | 25 | 38 | |||||||||||
Other investments (includes trading securities) | 27 | 8 | (25 | ) | 16 | ||||||||||
Net investment income | $ | 52 | $ | 87 | $ | 32 | $ | 141 | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Net gains (losses) on securities sold or called | $ | 9 | $ | 10 | $ | 16 | $ | 30 | ||||||||
Net foreign exchange gains (losses) | 1 | 26 | 3 | 23 | ||||||||||||
Credit impairments | — | — | — | — | ||||||||||||
Intent / requirement to sell impairments | — | — | — | — | ||||||||||||
Total net realized gains (losses) | $ | 10 | $ | 36 | $ | 18 | $ | 53 | ||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
RMBS | $ | (35 | ) | $ | (69 | ) | $ | (118 | ) | $ | (108 | ) | ||||
Domestic Public Finance | 42 | 50 | 220 | 120 | ||||||||||||
Student Loans | 4 | (4 | ) | 18 | (7 | ) | ||||||||||
Ambac UK and Other Credits | 5 | (111 | ) | 12 | (125 | ) | ||||||||||
Totals (1) | $ | 16 | $ | (134 | ) | $ | 132 | $ | (121 | ) | ||||||
(1) | Includes loss expenses incurred (benefit) of $34 and $37 for the three and six months ended June 30, 2020, respectively, and ($1) and $28 for the three and six months ended June 30, 2019, respectively. |
• | Higher projected losses in domestic public finance driven mostly by lower discount rates (primarily relating to Puerto Rico) and incurred losses related to transactions directly impacted by the economic impact from COVID-19; and |
• | An increase in student loan losses as a result of lower discount rates and the impact from COVID-19; partially offset by |
• | Favorable RMBS development as a result of the positive impact of lower interest rates on excess spread, reduced by the negative impact of lower discount rates and expected losses from COVID-19 related delinquencies/defaults. |
• | Favorable development within Ambac UK and Other Credits primarily due to the Ballantyne commutation; |
• | Favorable RMBS development as a result of credit improvement, a trustee settlement related to Lehman sponsored transactions of $19 million and the impact on excess spread from declines in interest rates; partially offset by, |
• | Higher projected losses in domestic public finance driven mostly by lower discount rates and additions to Puerto Rico loss reserves. |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Compensation | $ | 11 | $ | 17 | $ | 25 | $ | 32 | ||||||||
Non-compensation | 10 | 12 | 19 | 22 | ||||||||||||
Gross operating expenses | 20 | 29 | 44 | 54 | ||||||||||||
Reinsurance commissions, net | — | — | — | — | ||||||||||||
Total operating expenses | $ | 21 | $ | 29 | $ | 44 | $ | 54 | ||||||||
• | Lower compensation costs primarily related to lower salaries resulting from continued right sizing of staffing levels and incentive compensation costs related to changes in performance metrics primarily impacted by the Ballantyne restructuring and |
• | Lower non-compensation costs primarily due to reduced legal and consulting services. |
• | Lower compensation costs primarily due to lower salaries resulting from continued right sizing of staffing levels and incentive compensation costs related to changes in performance metrics primarily impacted by the Ballantyne restructuring and |
• | Lower non-compensation costs primarily due to a UK Value Added Tax (VAT) refund recognized in the six months ended June 30, 2020, and reduced consulting services. |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||
($ in millions) | 2020 | 2019 | 2020 | 2019 | ||||||||||||
Surplus notes (1) | $ | 24 | $ | 24 | $ | 50 | $ | 48 | ||||||||
Ambac note | 27 | 37 | 58 | 74 | ||||||||||||
Tier 2 notes | 7 | 6 | 14 | 13 | ||||||||||||
Other | — | — | — | — | ||||||||||||
Total interest expense | $ | 58 | $ | 67 | $ | 122 | $ | 135 | ||||||||
(1) | Includes junior surplus notes |
• | Pursuant to the amended and restated tax sharing agreement among AFG, Ambac Assurance and certain affiliates (the "Amended TSA"), Ambac Assurance is required to make payments ("tolling payments") to AFG with respect to the utilization of net operating loss carry-forwards (“NOLs”). AFG has accrued $28 million of tolling payments based on NOLs used by Ambac Assurance in 2017. In May 2018, AFG executed a waiver under the intercompany tax sharing agreement pursuant to which Ambac Assurance was relieved of the requirement to make this payment by June 1, 2018. AFG also agreed to defer the tolling payment for the use of net operating losses by Ambac Assurance in 2017 until such time as OCI consents to the payment. |
• | Under an inter-company cost allocation agreement, AFG is reimbursed by Ambac Assurance for a portion of certain operating costs and expenses and, if approved by OCI, entitled to an additional payment of up to $4 million per year to cover expenses not otherwise reimbursed. OCI approved this $4 million reimbursement for 2019 expenses, which was paid in March 2020. |
• | The COVID-19 pandemic has had a negative impact on Ambac's available liquidity as a consequence of the adverse reaction of the capital markets, which led to a reduction in the value and marketability of our invested assets; derivative losses, which required either timely settlement or additional collateral posting; and higher credit risk within the insured portfolio, as further described below. Nevertheless, Ambac has not yet experienced incremental demands on its liquidity, from higher claims or expenses, other than the aforementioned impact of derivatives. |
• | Claim payments may increase during the global recession and COVID-19 pandemic as issuers, particularly those with revenues that will be interrupted by the effects of the pandemic, including social distancing, other restrictions on activities and the increase in unemployment, may not have sufficient cash inflows to pay debt service on Ambac-insured debt. Refer to "Financial Guarantees in Force" in this Management's Discussion and Analysis for further discussion of the potential impact of the COVID-19 pandemic on claim payments. |
• | Interest and principal payments on surplus notes are subject to the approval of OCI, which has full discretion over payments regardless of the liquidity position of Ambac Assurance. Any such payment on surplus notes would require either payment or collateralization of a portion of the Tier 2 Notes under the terms of the Tier 2 Note indenture. See Note 13. Long-term Debt in the Notes to Consolidated Financial Statements, included in Part II, Item 8, in the Company's Annual Report on Form 10-K for the year ended December 31, 2019 for further discussion of the payment terms and conditions of the Tier 2 Notes. As discussed more fully in "Results of Operations" above in this Management's Discussion and Analysis, OCI declined Ambac Assurance's request to pay the principal amount of the surplus notes, plus all accrued and unpaid interest thereon, on June 7, 2020. |
Six Months Ended June 30, | |||||||
($ in million) | 2020 | 2019 | |||||
Cash provided by (used in): | |||||||
Operating activities | $ | (112 | ) | $ | (265 | ) | |
Investing activities | 270 | 313 | |||||
Financing activities | (205 | ) | (85 | ) | |||
Foreign exchange impact on cash and cash equivalents | — | — | |||||
Net cash flow | $ | (47 | ) | $ | (37 | ) | |
• | Cash used in operating activities relating to debt service on the Ambac Note was $58 million and $74 million for the six months ended June 30, 2020 and 2019, respectively. |
• | Cash used in operating activities related to interest rate derivatives was $19 million and $51 million for the six months ended June 30, 2020 and 2019, respectively. |
• | Cash used by operating activities relating to operating expenses was $44 million and $46 million for the six months ended June 30, 2020 and 2019, respectively. |
• | Cash provided by operating activities relating to the investment portfolio was $58 million and $73 million for the six months ended June 30, 2020 and 2019, respectively. |
• | Net loss and loss expenses paid, including commutation payments, during the six months ended June 30, 2020 and 2019 are detailed below: |
Six Months Ended June 30, | |||||||
($ in million) | 2020 | 2019 | |||||
Net loss and loss expenses paid (recovered): | |||||||
Net losses paid (1) | $ | 64 | $ | 298 | |||
Net subrogation received (2) | (56 | ) | (114 | ) | |||
Net loss expenses paid | 53 | 10 | |||||
Net cash flow | $ | 61 | $ | 194 | |||
(1) | Net losses paid include commutation payments of $2 and $213 for the six months ended June 30, 2020 and 2019, respectively. |
(2) | For or the six months ended June 30, 2019, subrogation received includes $36 of settlement proceeds related to Lehman sponsored RMBS transactions and $23 related to the COFINA Plan of Adjustment. |
($ in millions) | June 30, 2020 | December 31, 2019 | ||||||
Fixed income securities | $ | 2,218 | $ | 2,577 | ||||
Short-term | 692 | 653 | ||||||
Other investments | 401 | 478 | ||||||
Fixed income securities pledged as collateral | 155 | 85 | ||||||
Total investments (1) | $ | 3,466 | $ | 3,792 | ||||
(1) | Includes investments denominated in non-US dollar currencies with a fair value of £278 ($344) and €28.3 ($31.8) as of June 30, 2020, and £257 ($341) and €2 ($2) as of December 31, 2019. |
($ in millions) | June 30, 2020 | December 31, 2019 | ||||||
Other asset-backed securities | ||||||||
Military Housing | $ | 228 | $ | 237 | ||||
Other | 60 | 50 | ||||||
Total other asset-backed securities | $ | 288 | $ | 287 | ||||


(1) | Ratings are based on the lower of Moody’s or S&P ratings. If ratings are unavailable from Moody's or S&P, Fitch ratings are used. If guaranteed, rating represents the higher of the underlying or guarantor’s financial strength rating. |
(2) | Below investment grade and not rated bonds insured by Ambac represent 38% and 33% of the June 30, 2020 and December 31, 2019 combined fixed income portfolio, respectively. |
Currency (Amounts in millions) | Premium Receivable in Payment Currency | Premium Receivable in U.S. Dollars | ||||||
U.S. Dollars | $ | 243 | $ | 243 | ||||
British Pounds | £ | 103 | 127 | |||||
Euros | € | 19 | 22 | |||||
Total | $ | 392 | ||||||
Present Value of Expected Net Cash Flows | Unearned Premium Revenue | Gross Loss and Loss Expense Reserves | ||||||||||||||
($ in millions) Balance Sheet Line Item | Claims and Loss Expenses | Recoveries (1) | ||||||||||||||
June 30, 2020: | ||||||||||||||||
Loss and loss expense reserves | $ | 2,134 | $ | (238 | ) | $ | (82 | ) | $ | 1,814 | ||||||
Subrogation recoverable | 120 | (2,336 | ) | — | (2,215 | ) | ||||||||||
Totals | $ | 2,254 | $ | (2,573 | ) | $ | (82 | ) | $ | (401 | ) | |||||
December 31, 2019: | ||||||||||||||||
Loss and loss expense reserves | $ | 1,835 | $ | (233 | ) | $ | (54 | ) | $ | 1,548 | ||||||
Subrogation recoverable | 131 | (2,160 | ) | — | (2,029 | ) | ||||||||||
Totals | $ | 1,966 | $ | (2,394 | ) | $ | (54 | ) | $ | (482 | ) | |||||
(1) | Present value of future recoveries includes R&W subrogation recoveries of $1,757 and $1,727 at June 30, 2020 and December 31, 2019, respectively. |
Gross Par Outstanding (1)(2) | Present Value of Expected Net Cash Flows | Unearned Premium Revenue | Gross Loss and Loss Expense Reserves (1)(3) | |||||||||||||||||
($ in millions) | Claims and Loss Expenses | Recoveries | ||||||||||||||||||
June 30, 2020: | ||||||||||||||||||||
RMBS | $ | 2,769 | $ | 707 | $ | (2,193 | ) | $ | (13 | ) | $ | (1,499 | ) | |||||||
Domestic Public Finance | 3,714 | 1,197 | (344 | ) | (54 | ) | 799 | |||||||||||||
Student Loans | 445 | 269 | (36 | ) | (4 | ) | 229 | |||||||||||||
Ambac UK and Other Credits | 896 | 24 | — | (11 | ) | 13 | ||||||||||||||
Loss expenses | — | 57 | — | — | 57 | |||||||||||||||
Totals | $ | 7,824 | $ | 2,254 | $ | (2,573 | ) | $ | (82 | ) | $ | (401 | ) | |||||||
December 31, 2019: | ||||||||||||||||||||
RMBS | $ | 3,027 | $ | 634 | $ | (2,013 | ) | $ | (13 | ) | $ | (1,392 | ) | |||||||
Domestic Public Finance | 2,398 | 1,007 | (344 | ) | (36 | ) | 627 | |||||||||||||
Student Loans | 472 | 248 | (36 | ) | (4 | ) | 208 | |||||||||||||
Ambac UK and Other Credits | 271 | 4 | — | (1 | ) | 3 | ||||||||||||||
Loss expenses | — | 73 | — | — | 73 | |||||||||||||||
Totals | $ | 6,168 | $ | 1,966 | $ | (2,394 | ) | $ | (54 | ) | $ | (482 | ) | |||||||
(1) | Ceded par outstanding on policies with loss reserves and ceded loss and loss expense reserves are $866 and $35 respectively, at June 30, 2020, and $511 and $26, respectively at December 31, 2019. Ceded loss and loss expense reserves are included in Reinsurance recoverable on paid and unpaid losses. |
(2) | Gross Par Outstanding includes capital appreciation bonds, which are reported at the par amount at the time of issuance of the insurance policy as opposed to the current accreted value of the bond. |
(3) | Loss reserves are included in the balance sheet as Loss and loss expense reserves or Subrogation recoverable dependent on if a policy is in a net liability or net recoverable position. |
June 30, 2020 | December 31, 2019 | |||||||||||||||
Issuer Type ($ in millions) | Gross Par Outstanding (1) | Gross Loss Reserves | Gross Par Outstanding (1) | Gross Loss Reserves | ||||||||||||
Lease and tax-backed | $ | 1,468 | $ | 729 | $ | 1,075 | $ | 561 | ||||||||
General obligation | 614 | (20 | ) | 681 | (16 | ) | ||||||||||
Housing | 456 | 28 | 457 | 29 | ||||||||||||
Transportation revenue | 231 | 48 | 88 | 42 | ||||||||||||
Other | 945 | 14 | 97 | 11 | ||||||||||||
Total | $ | 3,714 | $ | 799 | $ | 2,398 | $ | 627 | ||||||||
(1) | Gross Par Outstanding includes capital appreciation bonds, which are reported at the par amount at the time of issuance of the insurance policy as opposed to the current accreted value of the bond. |
($ in millions) | June 30, 2020 | December 31, 2019 | ||||||
Surplus notes (1) | $ | 785 | $ | 769 | ||||
Ambac note | 1,659 | 1,763 | ||||||
Tier 2 notes | 292 | 278 | ||||||
Ambac UK debt | 13 | 13 | ||||||
Total Long-term Debt | $ | 2,749 | $ | 2,822 | ||||
(1) | Includes junior surplus notes. |
• | Non-credit impairment fair value (gain) loss on credit derivatives: Elimination of the non-credit impairment fair value gains (losses) on credit derivatives, which is the amount in excess of the present value of the expected estimated credit losses. Such fair value adjustments are affected by, and in part fluctuate with changes in market factors such as interest rates and credit spreads, including the market’s perception of Ambac’s credit risk (“Ambac CVA”), and are not expected to result in an economic gain or loss. These adjustments allow for all financial guarantee contracts to be accounted for consistent with the Financial Services – Insurance Topic of ASC, whether or not they are subject to derivative accounting rules. |
• | Insurance intangible amortization: Elimination of the amortization of the financial guarantee insurance intangible asset that arose as a result of Ambac’s emergence from bankruptcy and the implementation of Fresh Start reporting. This adjustment ensures that all financial guarantee contracts are accounted for consistent with the provisions of the Financial Services – Insurance Topic of the ASC. |
• | Foreign exchange (gains) losses: Elimination of the foreign exchange gains (losses) on the re-measurement of assets, liabilities and transactions in non-functional currencies. This adjustment eliminates the foreign exchange gains (losses) on all assets, liabilities and transactions in non-functional currencies, which enables users of our financial statements to better view the results without the impact of fluctuations in foreign currency exchange rates and facilitates period-to-period comparisons of Ambac's operating performance. |
Three Months Ended June 30, | |||||||||||||||
2020 | 2019 | ||||||||||||||
($ in millions, except share data) | $ Amount | Per Diluted Share | $ Amount | Per Diluted Share | |||||||||||
Net income (loss) attributable to common stockholders | $ | (35 | ) | $ | (0.77 | ) | $ | (128 | ) | $ | (2.79 | ) | |||
Adjustments: | |||||||||||||||
Non-credit impairment fair value (gain) loss on credit derivatives | (1 | ) | (0.01 | ) | — | — | |||||||||
Insurance intangible amortization | 14 | 0.30 | 226 | 4.92 | |||||||||||
Foreign exchange (gains) losses | (2 | ) | (0.04 | ) | (11 | ) | (0.25 | ) | |||||||
Adjusted earnings (loss) | $ | (24 | ) | $ | (0.52 | ) | $ | 86 | $ | 1.88 | |||||
Six Months Ended June 30, | |||||||||||||||
2020 | 2019 | ||||||||||||||
($ in millions, except share data) | $ Amount | Per Diluted Share | $ Amount | Per Diluted Share | |||||||||||
Net income (loss) attributable to common stockholders | $ | (315 | ) | $ | (6.83 | ) | $ | (172 | ) | $ | (3.74 | ) | |||
Adjustments: | |||||||||||||||
Non-credit impairment fair value (gain) loss on credit derivatives | 1 | 0.02 | (1 | ) | (0.01 | ) | |||||||||
Insurance intangible amortization | 27 | 0.58 | 263 | 5.72 | |||||||||||
Foreign exchange (gain) loss | (2 | ) | (0.04 | ) | (13 | ) | (0.29 | ) | |||||||
Adjusted earnings (loss) | $ | (289 | ) | $ | (6.27 | ) | $ | 77 | $ | 1.68 | |||||
• | Non-credit impairment fair value losses on credit derivatives: Elimination of the non-credit impairment fair value loss on credit derivatives, which is the amount in excess of the present value of the expected estimated economic credit loss. GAAP fair values are affected by, and in part fluctuate with, changes in market factors such as interest rates, credit spreads, including Ambac’s CVA that are not expected to result in an economic gain or loss. These adjustments allow for all financial guarantee contracts to be accounted for within Adjusted Book Value consistent with the provisions of the Financial Services—Insurance Topic of the ASC, whether or not they are subject to derivative accounting rules. |
• | Insurance intangible asset: Elimination of the financial guarantee insurance intangible asset that arose as a result of Ambac’s emergence from bankruptcy and the implementation of Fresh Start reporting. This adjustment ensures that all financial guarantee contracts are accounted for within Adjusted Book Value consistent with the provisions of the Financial Services—Insurance Topic of the ASC. |
• | Net unearned premiums and fees in excess of expected losses: Addition of the value of the unearned premium revenue ("UPR") on financial guarantee contracts, in excess of expected losses, net of reinsurance. This non-GAAP adjustment presents the economics of UPR and expected losses for financial guarantee contracts on a consistent basis. In accordance with GAAP, stockholders’ equity reflects a reduction for expected losses only to the extent they exceed UPR. However, when expected losses are less than UPR for a financial guarantee contract, neither expected losses nor UPR have an impact on stockholders’ equity. This non-GAAP adjustment adds UPR in excess of expected losses, net of reinsurance, to stockholders’ equity for financial guarantee contracts where expected losses are less than UPR. |
• | Net unrealized investment (gains) losses in Accumulated Other Comprehensive Income: Elimination of the unrealized gains and losses on the Company’s investments that are recorded as a component of accumulated other comprehensive income (“AOCI”). The AOCI component of the fair value adjustment on the investment portfolio may differ from realized gains and losses ultimately recognized by the Company based on the Company’s investment strategy. This adjustment only allows for such gains and losses in Adjusted Book Value when realized. |
June 30, 2020 | December 31, 2019 | ||||||||||||||
($ in millions, except share data) | $ Amount | Per Share | $ Amount | Per Share | |||||||||||
Total Ambac Financial Group, Inc. stockholders’ equity | $ | 1,069 | $ | 23.34 | $ | 1,477 | $ | 32.41 | |||||||
Adjustments: | |||||||||||||||
Non-credit impairment fair value losses on credit derivatives | 1 | 0.03 | — | 0.01 | |||||||||||
Insurance intangible asset | (392 | ) | (8.57 | ) | (427 | ) | (9.37 | ) | |||||||
Net unearned premiums and fees in excess of expected losses | 396 | 8.63 | 414 | 9.09 | |||||||||||
Net unrealized investment (gains) losses in Accumulated Other Comprehensive Income | (109 | ) | (2.38 | ) | (151 | ) | (3.31 | ) | |||||||
Adjusted book value | $ | 965 | $ | 21.06 | $ | 1,313 | $ | 28.83 | |||||||
Item 3. | Quantitative and Qualitative Disclosures about Market Risk |
($ in millions) | Estimated Change in Net Fair Value | Estimated Net Fair Value | ||||||
300 basis point rise | $ | 18 | $ | (503 | ) | |||
200 basis point rise | 17 | (504 | ) | |||||
100 basis point rise | 15 | (506 | ) | |||||
Base scenario | — | (521 | ) | |||||
100 basis point decline(1) | 2 | (519 | ) | |||||
200 basis point decline(1) | 5 | (516 | ) | |||||
(1) | Incorporates an interest rate floor of 0%. |
($ in millions) | Estimated Change in Net Fair Value | Estimated Net Fair Value | ||||||
250 Basis Point Widening | $ | (24 | ) | $ | (61 | ) | ||
50 Basis Point Widening | (6 | ) | (43 | ) | ||||
Base Scenario | — | (37 | ) | |||||
50 basis Point Narrowing | 5 | (32 | ) | |||||
250 basis Point Narrowing | 25 | (12 | ) | |||||
($ in millions) | Estimated Change in Net Fair Value | Estimated Net Fair Value | ||||||
250 Basis Point Widening | $ | (134 | ) | $ | 1,895 | |||
50 Basis Point Widening | (27 | ) | 2,002 | |||||
Base Scenario | — | 2,029 | ||||||
50 Basis Point Narrowing | 25 | 2,054 | ||||||
250 Basis Point Narrowing | 75 | 2,104 | ||||||
Item 4. | Controls and Procedures. |
Item 1. | Legal Proceedings |
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds |
(a) | Unregistered Sales of Equity Securities — No matters require disclosure. |
(b) | Purchases of Equity Securities By the Issuer and Affiliated Purchasers |
April 2020 | May 2020 | June 2020 | Second Quarter 2020 | ||||||||||||
Total Shares Purchased (1) | — | 22,579 | — | 22,579 | |||||||||||
Average Price Paid Per Share | $ | — | $ | 13.67 | $ | — | $ | 13.67 | |||||||
Total Number of Shares Purchased as Part of Publicly Announced Plan (1) | — | — | — | — | |||||||||||
Maximum Number of Shares That may Yet be Purchased Under the Plan | — | — | — | — | |||||||||||
(1) | There were no other repurchases of equity securities made during the three months ended June 30, 2020. Ambac does not have a stock repurchase program. |
Item 3. | Defaults Upon Senior Securities — No matters require disclosure. |
Item 5. | Other Information |
Item 6. | Exhibits |
Exhibit Number | Description | |
Other exhibits, filed or furnished, as indicated: | ||
10.1+ | ||
10.2+ | ||
31.1+ | ||
31.2+ | ||
32.1++ | ||
101.INS | XBRL Instance Document - the instance document does not appear in the interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | |
101.SCH | XBRL Taxonomy Extension Schema Document. | |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. | |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. | |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. | |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. | |
104 | Cover Page Interactive Data File - The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags or embedded within the Inline XBRL document | |
+ Filed herewith. ++ Furnished herewith. | ||
AMBAC FINANCIAL GROUP, INC. | |||
Dated: | August 6, 2020 | By: | /S/ DAVID TRICK |
Name: | David Trick | ||
Title: | Chief Financial Officer and Treasurer (Duly Authorized Officer and Principal Financial Officer) | ||
(a) | Cash Dividend. If a dividend with respect to shares of Common Stock is payable in cash, then, as of the applicable dividend payment date, the Participant shall be credited with a right to receive a “Deferred Cash Dividend Equivalent” equal to (i) the cash dividend payable with respect to a share of Common Stock, multiplied by (ii) the number of Restricted Stock Units outstanding (i.e., the number of Restricted Stock Units granted hereunder less the number of such Restricted Stock Units that have settled in accordance with Section 5 below) on the applicable dividend record date. |
(b) | Stock Dividend. If a dividend with respect to shares of Common Stock is payable in shares of Common Stock, then, as of the dividend payment date, the Participant shall be credited with that number of “Dividend Equivalent Units” equal to (i) the number of shares Common Stock distributed in the dividend with respect to a share of Common Stock, multiplied by (ii) the number of Restricted Stock Units outstanding on the applicable dividend record date. |
(a) | Service Vesting. Subject to the Participant’s continuing service on the Board of Directors, and the terms and conditions of this Agreement and the Plan, all of the Restricted Stock Units and associated Dividend Equivalents awarded hereunder shall vest on April 30, 2021. |
(b) | Accelerated Vesting. All Awards and associated Dividend Equivalents shall vest upon (i) a Change in Control (as defined below), (ii) if Participant is determined to be disabled or in the event of the death of Participant or (ii) in the event of the Participant’s involuntary removal other than for cause from the Board of Directors; provided that no Award shall vest by virtue of the Participant’s removal from the Board of Directors pursuant to a vote of Ambac’s stockholders at Ambac’s regularly scheduled annual meeting of stockholders. For purposes of this Agreement, “Change in Control” shall mean a change in the ownership or effective control of Ambac, or a change in the ownership of a substantially all of the assets of Ambac within the meaning of Regs. Section 1.409A-3(i)(5) under Section 409A of the Code. |
(c) | Removal Upon Regular Stockholder Vote/Voluntary Resignation. All unvested Awards under this Agreement shall immediately terminate and shall be forfeited and the Participant shall have no further rights with respect to such Awards and associated Dividend Equivalents upon the removal of the Participant from the Board of |
(d) | Removal For Cause. All Awards and associated Dividend Equivalents under this Agreement, whether or not vested, shall immediately terminate and shall be forfeited and the Participant shall have no further rights with respect to such Awards upon the removal of the Participant from the Board of Directors for cause, which results in economic harm to the Company, as determined in good faith by the Board of Directors in accordance with applicable law and the Company’s by-laws and articles of incorporation. |
(a) | Compliance. Notwithstanding anything herein to the contrary, this Agreement is intended to be interpreted and applied so that the payments and benefits set forth herein either shall either be exempt from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), or shall comply with the requirements of Code Section 409A, and, accordingly, to the maximum extent permitted, this Agreement shall be interpreted to be exempt from or in compliance with Code Section 409A. |
(b) | Separate Payments. Notwithstanding anything in this Agreement to the contrary, the right to receive installment payments hereunder shall be treated as a right to receive a series of separate payments in accordance with Code Section 409A and Final Treasury Regulation Section 1.409A-2(b)(2)(iii). |
(c) | Short-Term Deferral. Except as otherwise specifically provided, amounts payable under this Agreement, other than those expressly payable on a deferred or installment basis, will be paid as promptly as practicable following the date they are earned and vested and, in any event, on or prior to March 15 of the year following the first calendar year in which such amounts are no longer subject to a substantial risk of forfeiture, as such term is defined in Section 409A of the Code. |
(d) | Separation from Service. Notwithstanding anything in this Agreement or elsewhere to the contrary, a termination of Participant’s service with the Board of Directors shall not be deemed to have occurred for purposes of any provision of this Agreement providing for the payment of any amounts or benefits that constitute “non-qualified deferred compensation” within the meaning of Code Section 409A upon or following a termination of Participant’s service unless such termination is also a “separation from service” within the meaning of Code Section 409A and, for purposes of any such provision of this Agreement, references to a “termination,” “termination of service” or like terms shall mean “separation from service” and the date of such separation from service shall be the “Termination Date” for purposes of any such payment or benefits. |
(e) | No Designation. In no event may Participant, directly or indirectly, designate the calendar year of any payment to be made under this Agreement or otherwise that constitutes a “deferral of compensation” within the meaning of Code Section 409A. |
(i) | If to AFG or AAC, to both: |
(ii) | If to the Executive: |
1. | I have reviewed this Quarterly Report on Form 10-Q of Ambac Financial Group, Inc. (the "registrant"); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a—15(e) and 15d—15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors: |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | August 6, 2020 | By: | /s/ Claude LeBlanc |
Claude LeBlanc President and Chief Executive Officer | |||
1. | I have reviewed this Quarterly Report on Form 10-Q of Ambac Financial Group, Inc. (the"registrant"); |
2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
4. | The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a—15(e) and 15d—15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
a. | Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
b. | Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
c. | Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
d. | Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors: |
a. | All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
b. | Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
Dated: | August 6, 2020 | By: | /s/ David Trick |
David Trick Chief Financial Officer and Treasurer | |||
(1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
(2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
By: | /s/ Claude LeBlanc | ||
Name: | Claude LeBlanc | ||
Title: | President and Chief Executive Officer | ||
By: | /s/ David Trick | ||
Name: | David Trick | ||
Title: | Chief Financial Officer and Treasurer | ||
Dated: | August 6, 2020 | ||